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Abstract: The era of the Anthropocene poses unprecedented challenges and affects 
human health, concerning above all socially and economically vulnerable groups. This 
study suggests a human rights-based approach and assesses the solutions adopted in the 
framework of the European Union and of the Council of Europe for ensuring a better 
and more equitable access to healthcare, by also taking into consideration the 
jurisprudence of the Court of Justice of the European Union and of the European Court 
of Human Rights. From this perspective, some human rights-based solutions are 
advanced in light of the opportunities offered by biotechnology, pharmacogenetics of 
pharmacogenomics, gene therapy and regenerative medicine in a reality where 
transhumanism, as a result of the application of the advanced scientific achievements, is 
no longer a remote possibility. 
Resumen: La época del Antropoceno conlleva desafíos sin precedentes e interesa la 
salud humana, afectando sobre todo los grupos social y economicamente vulnerables y 
requierendo soluciones adecuadas y equitativas a todos los niveles de gobernación. El 
presente estudio sugiere un enfoque basado en los derechos humanos y analiza las 
soluciones adoptadas en el contexto de la Unión Europea y del Consejo de Europa para 
garantizar un mejor y más justo acceso a la asistencia sanitaria, tomando además en 
considearación la jurisprudencia del Tribunal de Justicia de la Unión Europea y del 
Tribunal Europeo de los Derechos Humanos. Por ende, se proponen unas soluciones 
basadas en los derechos humanos a la luz de las oportunidades que la biotecnología, la 
farmacogenética o farmacogenómica, la terapia génica y la medicina regenerativa 
ofrecen en una realidad en la que el transhumanismo como resultado de las más 
avanzadas aplicaciones científicas no parece más una posibilidad remota. 
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In 2016, the Working Group on the Anthropocene has suggested that the mid-20th 
Century be adopted as the moment that marked the transition of the Earth from the 
geological Age of the Holocene into the geological Era of the Anthropocene.  
The notion of “Anthropocene” was advanced by biologist Eugene F. Stoermer and 
popularized by the Dutch Chemist and Nobel Prize winner Paul Crutzen in 2000.
1
 This 
conception refers to the era where “the many geologically significant conditions and 
processes are profoundly altered by human activities”. Although the earliest events that 
triggered the process that led up to the Anthropocene date back even to the development 
of early agricultural society, about 5000 to 8000 years ago, and some imprint in 
geological strata was left since about 1800 at the times of the Industrial Revolution, it 
was in the mid-20th Century that the so-called “Great Acceleration” took place.2 
Among the human activities responsible for speeding up the advent of the 
Anthropocene, we can mention, for instance, methane production by cattle, fishing, 
wasteful use of nitrogen and phosphorus in fertilisers, the use of fossil fuels and plastics 
and, in general, overexploitation of resources.  
The consequences are massive and often overwhelming: primarily, climate change 
and, among the various aftermaths, flooding, sea level rise, ocean acidification, loss of 
biodiversity, large scale species extinction, which are all capable of impacting human 
                                                             
1 ZALASIEWICZA, J., WATERS, C. N., SUMMERHAYES, C. P., WOLFE, A. P., BARNOSKY, A. D., 
CEARRETA, A., CRUTZEN, P., ELLIS, E., FAIRCHILD, I. J., GAŁUSZKA, A., HAFF, P., HAJDAS, 
I., HEAD, M. J., IVAR DO SUL, J. A., JEANDEL, C., LEINFELDER, R., MCNEILL, J.R., NEAL, C., 
ODADA, E., ORESKES, N., STEFFEN, W., SYVITSKI, J., VIDAS, D., WAGREICH, M., WILLIAMS, 
M., “The Working Group on the Anthropocene: Summary of evidence and interim recommendations”, 
Anthropocene, n° 19, 2017, pp. 55–60. ELHERS, E., KRAFFT, T., Earth System Science in the 
Anthropocene, Berlin, Heidelberg, Springer, 2006. 
2 WATERS, C.N., SUMMERHAYES, C. P., WOLFE, A. P., BARNOSKY, A. D., “The Working Group 
on the Anthropocene: Summary of evidence and interim recommendations”, Anthropocene, n° 19”, 2017, 
pp. 55–60; HEY, E., “International Law and the Anthropocene”, ESIL Reflections, n° 5 (10), 2016. See in 
particular, SCOTT, K. N., “International Law in the Anthropocene: Responding to the Geoengineering 
Challenge”, Michigan Journal of International Law, n° 34 (2), 2013. 
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health from many viewpoints.  For example, due to water pollution, to reduced crop 
yields and to the deterioration of the quality of food given the loss of micronutrient 
caused by the use of carbon dioxide fertilization, which alter food quality.
3
 Again, 
climate change can be a determining factor for the spread of epidemics, as the Zika 
virus outbreak has recently demonstrated, and natural catastrophes can be a major 
challenge for disaster health management systems.
4
 
The adverse effects on human health can even come to affect the genetic dimension 
from an epigenetic perspective,
5
 by triggering gene expression and thus determining the 
onset of several genetic diseases and by causing epigenetic mutations. The epigenetic 
consequences of the impact of Anthropocene on human health can be quite wide in 
time, as they can be transmitted to future generations both intergenerationally – as they 
can affect the child during pregnancy - and transgenerationally.     
The Report issued by the Rockefeller Foundation/Lancet Commission on Planetary 
Health
6
 in 2015 clearly described how human health directly depends on the state of the 
natural systems and, among its recommendations, also called for developing adequate 
research capacity in this respect. 
It goes without saying that the Anthropocene requires appropriate States’ rethinking 
of their policies and allocation of resources not only as far as it concerns research, 
which plays a basic role in order to identify and assess specific health risks posed by the 
peculiar effects of the Anthropocene, but as far as it regards the elaboration of wide 
                                                             
3 WATERS, C.N., SUMMERHAYES, C. P., WOLFE, A. P., BARNOSKY, A. D., “The Working Group 
on the Anthropocene: Summary of evidence and interim recommendations”, cited above, n. 2; SCOTT, 
K. N., “International Law in the Anthropocene: Responding to the Geoengineering Challenge”, cited 
above, n. 2; HAINES, A., “Addressing challenges to human health in the Anthropocene epoch—an 
overview of the findings of the Rockefeller/Lancet Commission on Planetary Health”, Public Health 
Reviews, n° 37 (14), 2016, pp. 1-5. 
4 See KOTZÉ, L. J., “Rethinking Global Environmental Law and Governance in the Anthropocene”, 
Journal of Energy and Natural Resources Law, n° 32 (2), 2014. 
5 FAVÉ, M. J., LAMAZE, F. C., SOAVE, D., HODGKINSON, A., GAUVIN, H., BRUAT, V., 
GRENIER, J. C., GBEHA, E., SKEAD, K., SMARGIASSI, A., JOHNSON, M., IDAGHDOUR, Y., 
AWADALLA, P., “Gene-by-environment interactions in urban populations modulate risk phenotypes”, 
Nature Communications, n° 9, 2018, pp. 827-838. 
6 The Lancet, “The Rockefeller Foundation Lancet Commission Report on Planetary Health”, available at 
https://www.cbd.int/health/planetaryhealth/default.shtml accessed 14 September 2018. 
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scale preventive and therapeutic strategies and accessibility of health care. Clearly, it is 
not an easy task, especially considering the global financial crisis which has affected our 
world since the late 2000 and the adoption of austerity measures that it has brought 




Under this premise, the purpose of this paper is taking into account how the 
diagnostic and therapeutic means made available by scientific progress, putting 
particular emphasis to the most advanced ones as genome editing, human therapeutic 
cloning, pharmacogenetics or pharmacogenomics, regenerative medicine may help to 
tackle the challenges that characterize the era of the Anthropocene and the threats it 
poses to human health, consistently with the principles of international biolaw. 
The starting point of this reflection is assessing whether advanced biotechnologies 
and bioengineering, as the most evolutionary horizon of science, may help to face with 
the unprecedented challenges that the new geological era is posing. In particular, the 
view that inspired this reflection is whether the Anthropocene may ease the affirmation 
of the views supported by transhumanism.   
In this regard, it should be primarily stressed that the conception of transhumanism 
has evolved and has assumed more specific and peculiar shades in light of scientific 
progress since Julian Huxley elaborated it in 1927.
8
 
Transhumanism was intended as the possibility for man and mankind to express the 
highest potentiality of human nature, as the full realization of the potential of human 
nature, for human nature; a process to be intended individually, but for the whole 
human species, for the whole mankind, through the “energic exploration” of science and 
                                                             
7 QUAGLIO, G. L., KARAPIPERIS, T., VAN WOENSEL, L., ARNOLD, E., MCDAID, D., “Austerity 
and health in Europe”, Health Policy, n° 113 (1–2), November 2013, Pages 13-19; STUCKLER, D., 
REEVES, A., LOOPSTRA, R., KARANIKOLOS, M., MCKEE, M., “Austerity and health: the impact in 
the UK and Europe”, European Journal of Public Health, n° 27, Supplement 4, 2017, pp. 18–21. Also 
see: WILLIAMS, D., THOMAS, S., “The impact of austerity on the health workforce and the 
achievement of human resources for health policies in Ireland (2008–2014)”, Human Resources for 
Health, n° 15 (62), 2017. RUCKERT, A., LABONTÉ, R., “The global financial crisis and health equity: 
Early experiences from Canada”, Global Health, n° 10 (2), 2014. 
8 HUXLEY, J., “Transhumanism”, Journal of Humanistic Psychology, n° 8 (1), 1968, pp. 73-76. 
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the possibilities that it offers. Transhumanism, in the view of Huxley, is intended as a 
new existence where the human being, individually and collectively, with regard to the 
mankind, is free from the suffering that affect him. There is a logic of solidarity that 
cannot be overlooked, and which can inspire an ethical and human rights-based 
response to the challenges posed by the adverse effects of the advent of the 
Anthropocene on human health, with special regard to the socially and economically 
vulnerable people.
9
 In fact, socially and economically precarious conditions of life 
expose to higher risks of exclusion from the enjoyment of healthcare, even basic health 
services. This is so because several gaps can be found in the social protection they can 
enjoy, especially social health protection, which is due to a number of reasons. For 
example, in the context of our analysis, gaps in statutory coverage, financial protection 
and specific eligibility criteria, coupled with limited scope of benefits are factors of 
basic importance.
10
 This is why this study focuses on making accessibility to healthcare 
viable, through the adoption of a human rights-based approach as the suitable way for 
pursuing this purpose, and for including not only basic healthcare but also the advanced 
therapeutic achievements of scientific progress. 
This is all the more true since the means made available by scientific progress are 
now capable of making the transcendence of the human nature a reality, through a 
number of achievements that can affect the human being from several viewpoints, first 
of all genetically. After the sequencing of the human genome, we have entered the post-
genomic era. Genetics is not merely intended in relation to inheritance of genetic traits, 
but it deeply surveys the molecular processes related to inheritance and has come to 
                                                             
9 In the context of this study, we intend socio-economic vulnerability as a condition that, due to the lack 
of adequate cultural background and to critical economic situation, hampers or even precludes access to 
healthcare. See: European Union, New study from EU RAMSES project assesses vulnerability of 
European Cities to Climate Change, available at https://www.pattodeisindaci.eu/news-ed-
eventi/news/1545-assessing-european-cities-vulnerability-to-climate-change.html, accessed 14 September 
2018. European Union Climate Adaptation, Climate -  ADAPT -Sharing adaptation information across 
Europe, Assessing Risks and Vulnerability to Climate Change, available at https://climate-
adapt.eea.europa.eu/knowledge/tools/adaptation-support-tool/step-2 accessed 14 September 2018. 
LANGEVELD, H., RÖLING N.G., Changing European Farming Systems for a Better Future: New 
Visions for Rural Areas, Wageningen, Wageningen Academic Publishers, 2006. 
10 SCHEIL-ADLUNG, X., KUHL, C., “Addressing inequities in access to health care for vulnerable 
groups in countries of Europe and Central Asia”, Global Campaign on Social Security and Coverage for 
All, Social Security Department - International Labour Office, International Labour Organization, 2011. 
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assume the dimensions of the genetics of populations.
11
 The ethical issues related to 
human germline and somatic alterations and to human therapeutic cloning have 
assumed primary importance in the bioethical discourse, as well as human cloning that 
has raised a complicated debate at the global level at the United Nations and at the 
UNESCO that has highlighted the difficulty to reconcile different views.
12
 Genetic 
therapy, pharmacogenetics or pharmacogenomics and regenerative medicine have 
lightened huge hope worldwide and now offer innovative therapeutic means that imply 
some manipulation of the human body. 
That being said, we should then question: is the time ripe for the “neuro-bio-info-
nano machine” without setting aside human rights, equality and social justice?13 
This study aims to provide a response to this query in relation to the two major 
European realities, the European Union and the Council of Europe, for assessing how a 
similar approach might find justification and implementation in their respective 
frameworks, through reference to international law and the core conception of the right 
to health and access to health from an evolutionary view point, expanding on the 
possible evolutionary horizons of the right to science. 
2. A NEW ERA, MAYBE A NEW MAN BETWEEN 
ETHICS, RIGHTS AND STATE POLICY  
Since its theorization, the Anthropocene has increasingly gained ground in the 
international debate in different fields of knowledge. 
When the various approaches to the Anthropocene and in particular to climate 
change as one of its major implications, are taken into consideration, it can be quite 
soon observed that bioethics has so far dedicated very poor attention to these issues. 
                                                             
11 RAPISARDA, I., Il corpo umano come oggetto di diritto nell’era biotecnologica, PhD Thesis, Doctoral 
School of “Diritto Europeo dei Contratti Civili, Commerciali e del Lavoro”, Ciclo XXVIII, Università 
Ca’ Foscari di Venezia, p. 122. 
12 KUPPUSWAMY, C., MACER, D., SERBULEA, M., TOBIN, B., United Nations University – 
Institute of Advanced Studies, Biodiplomacy Programme, “Is Human Reproductive Cloning Inevitable: 
Future Options for UN Governance”, 2007. 
13 RODOTÀ, S., Il diritto di avere diritti, Bari, Editori Laterza, 2012.  
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Some calls were made in scholarship advocating the need that bioethics join the 
scientific debate. 
As some scholars have highlighted, the reluctancy of bioethicist to engage in the 
reflection on Anthropocene is largely due to the influence of their traditional matters of 
interest (abortion, euthanasia, informed consent, access to health care too, for example) 
and to their usual operational field, which basically entails cooperation with health 
facilities, services and professionals. Usually the questions related to Anthropocene and, 
in general, to environment, are seen as distant concerns. 
However, since the manifold impact of the Anthropocene on health care implies 
necessarily a rethinking of State policies and budget management, a bioethical approach 
might help. As new challenges keep on emerging, it is necessary to cope with them by 
adopting new solutions, as for example the innovative means offered by biomedical 
progress. Action has to be promptly taken: the adoption of a renewed approach cannot 
be delayed as population is likely to be widely and transversally affected, to the 
particular detriment of socially and economically vulnerable subjects. Therefore, 
policies should be reconsidered in order to address society comprehensively and 
through enhancement of the protection of social rights, especially the right to health and 
accessibility of health care, and in order to cope with the related strong risks of 
discrimination of the most socially and economically vulnerable members of society. 
In his study “Just Health Care”,14 Professor. Norman Daniels highlighted three 
criteria of allocation of resources in public health and priority setting, namely:  
1) the market; 2) rights; 3) needs.  
The choice is particularly delicate when one considers the recent austerity policies 
and cuts to public spending due to the financial crisis the world’s been facing. 
                                                             
14 DANIELS, N., Just Health Care, Cambridge, Cambridge University Press, 1995. DANIELS, N., 
“Resource Allocation and Priority Setting”, in BARRETT, D.H., ORTMANN, L.H., DAWSON, A., 
SAENZ, C., REIS, A., BOLAN, G. (Eds.), Public Health Ethics: Cases Spanning the Globe, Berlin, 
Springer International Publishing, 2016. 
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  The privatization of health care in a growing number of countries and, in some 




The principles of bioethics seem to be capable of offering some precious guidance 
for shaping health policies and priority setting. 
Reference goes to dignity, autonomy, information, justice, solidarity, universality, 
vulnerability, non-maleficence and beneficence.
16
 
Dignity is defined in international law as “inherent” in the human being, a basic and 
inalienable feature of human essence. Although sometimes in scholarship, it was argued 
that it may end up being a void concept, as for instance Ruth Macklin,
17
 and that in 
practice other principles would structure its content, as autonomy, actually the 
fundamental role of human dignity is clearly recognized, along with its unifying nature 
as an inherent value of the individual and of the human species. It is especially from this 
transcendental viewpoint that human dignity can provides us guidance when assessing 
whether the new era of the Anthropocene may lead also the ascent of what we could call 
“a new man”, to whom we should question how much of the “original” human nature is 
left. 
Human dignity as a feature of our species is of basic importance when we consider 
how far we can reach through manipulation of the human being, either through 
alterations of the human genome with regard to the human germline or through the 
incorporation into the body of 3D-printed tissues and organs thank to the advances of 
bioengineering and regenerative medicine. 
Human dignity, in this regard, arguably provides important guidance in two senses: 
on the one hand for assessing the admissibility of specific practices and interventions on 
                                                             
15 DANIELS, N., “Resource Allocation and Priority Setting”, cited above, n. 14. 
16 ANDORNO, R., La bioética y la dignidad de la persona, Madrid, Editorial Tecnos – Grupo Anaya, 
2012, pp. 32 ff; ATIENZA, M., “El derecho sobre el propio cuerpo y sus consecuencias”, in CASADO, 
M., (ed.), De la solidaridad al mercado: el cuerpo humano y el comercio biotecnológico, Barcelona, 
Universitat de Barcelona, Edicions de la Universitat de Barcelona, 2017, pp. 35-63, 52 ff. 
17 MACKLIN, R., “Dignity is a useless concept”, British Medical Journal, n° 327, 2003, p. 1419. 
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the human beings, helping to clarify which of them can be helpful but, at the same time, 
respectful of the dignity and, we could also say, the integrity of the human being. On the 
other hand, human dignity provides guidance for the recognition and affirmation of a 
renewed understanding of human rights related to transhumanism. Indeed, in this 
regard, the issue is whether human rights and, especially, the conception of health and 
of the highest attainable standards of health protected under international law are 
capable of embracing access to the new tools made available by the scientific progress 
and, if so, to which extent. Could we someday invoke not just advanced therapeutic 
opportunities or could we enjoy the benefits of enhancing treatments? Of course, 
enhancement itself would require better definition, and human dignity can be very 
helpful of course, surely through further contextualization in relation of the specific 
scientific and legal circumstances as well. What is more, as is further analysed with 
regard to the evolutionary understanding of the core conception of health affirmed in 
international law in paragraph 5, human dignity as an inherent feature of the human 
species underlies the protection the human nature of the future generations from any 
dramatic and irreversible intervention that scientific achievements might allow to make, 
in order to promote the ethics of post-humanism. 
Along with human dignity, the bioethical and biolegal principles may help to define 
a feasible approach aimed at tackling the issues considered above: in particular, 
autonomy is of basic importance, along with the respect of information and, thus, of 
informed consent, to preserve the physical and mental integrity od the human being and 
its choice to embrace or not any possibility of evolving his nature. We could possibly 
call it a choice to remain human or, otherwise, to enjoy as far as possible, the benefits of 
scientific progress and its capacity to improve the human condition. Of course, this may 
be feasible only through adequate cooperation with physicians and effective 
implementation in advanced medical and scientific practice of beneficence and non-
maleficence, by pursing the benefit of the patient and that good produced by an 
immediate treatment is higher than the harm that might be caused for the patient.  In this 
respect, the “rights” perspective theorized by Professor Daniels can be helpful also to 
prevent any dangerous drift towards a market perspective, that might cause the 
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commodification of the patient. For example, one the most common hazard is that 
patients are exploited for experimentation: they might be captivated by promising 
experimentation of advanced treatments without adequate respect for their rights and for 
bioethical principles, by taking advantage of their socio-economic vulnerability. In this 
regard, the adverse effects of the advent of the era of the Anthropocene might 
exacerbate these risks, as to the deterioration of health conditions, for example 
epigenetically and surely conditions of socio-economic vulnerability would worsen such 
situation. 
The principles of universality, solidarity and justice may help to frame the social 
dimension of the question and provide guidance for appropriate allocation of resources 
and ensure accessibility to advanced health care, even when it encompasses such 
resources and means as those made available by biotechnology and regenerative 
medicine. Since the impact of the Anthropocene and its adverse effects on human health 
cannot be overlooked and may affect some areas more than others, particular exposure 
to the adverse environmental conditions of the new geological era might be included 
among the standards for allocation of new treatments among the population. In this 
regard, it is fundamental to be realistic: science is promising and sometimes even 
prodigious; but it goes without saying that it is expensive, and appropriate rethinking of 
State budget is necessary for ensuring equitable allocation and access, that should be 
especially ensured to the most vulnerable if we want to ensure social justice. In this 
regard, a combination of the standards of rights and need, as classified by Professor 
Daniels, would provide adequate framing and justification. 
When we focus on the European reality, two major regional frameworks provide the 
interesting landscape for analysis of feasibility of a similar approach. The next 
paragraphs respectively focus on the European Union and on the Council of Europe in 
order to assess how and whether a bioethical approach to advanced scientific progress, 
pushed to the horizons of transhumanism, might be advanced as a means for tackling 
the challenges that Anthropocene poses to the health of people in Europe. In this regard, 
in both frameworks, the first step of the analysis is to assess how accessibility to health 
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is understood and protected in the two systems, especially in relation to socio-
economical vulnerability, in order to further assess the role of scientific progress in each 
context and the possibility of a human rights-based and ethics consistent 
transhumanistic approach.  
3. THE VIABILITY OF A TRANSHUMANISTIC APPROACH 
IN THE LEGAL ORDER OF THE EUROPEAN UNION 
The assessment of the possible horizons of transhumanism in the Anthropocene in 
the European Union (EU) requires primary framing of healthcare and environmental 
issues, their framing within the EU legal order and the capacity of the EU Treaties to 
offer some justification to biolegal questions. Indeed, strictly speaking, biolaw falls 
outside the purview of the EU.
18
 Therefore, from a regional perspective, it helps to 
understand why, whilst bioethics is a thriving reality for the Council of Europe, dealing 
with this field has been a major challenge for the European Union, primarily, because 
no specific legal bases are provided in its legal framework. 
Nevertheless, the EU has been capable of developing an important approach to 
bioethics and to biolaw, by relying on several suitable legal bases that, as anticipated, 
can be found in the architecture of the Treaties,
19
 namely: Article 114 of the Treaty on 
the Functioning of the European Union (TFEU) on internal market; Article 168 TFUE 
on public health; Articles 179 and the following provisions of Title XIX, Part III of the 
TFEU on Research and technological development; Article 208 of the TFEU on 
development cooperation. 
These provisions have allowed the EU to adopt some remarkable acts, which have 
concurred to improve and harmonize the regional approach to bioethical issues of basic 
                                                             
18 Commission of the Bishops' Conferences of the European Community, “An Overview Report on 
Bioethics in the European Union”, Brussel, October 2009. 
19 European Union, Consolidated version of the Treaty on the Functioning of the European Union, 26 
October 2012, OJ L. 326/47-326/390; 26.10.2012, available at https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=celex%3A12012E%2FTXT accessed 13 September 2018.  
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importance. Noteworthy examples are Directive 98/44/EC
20
 on the Legal Protection of 
biotechnological inventions and Directive 2004/23/EC
21
 on setting standards of quality 
and safety for the donation, procurement, testing, processing of human tissues and cells.  
When the focus is set on the competence of the EU with regard to health care, the 
reference legal basis is primarily Article 168 of the TFEU, whose wording eloquently 
recalls the principle of subsidiarity, which appears consistent with the nature of the EU 
competence in relation to “the protection and improvement of human health”. In fact, in 
the post-Lisbon framework, this area was incorporated in Article 6 sub (a) of the TFEU, 
which concerns the activities of the Member States in relation to which the Union is 
competent to carry out actions of support, coordination or supplement with regard to 
their European dimension. This area of EU competence is characterized by the 
exclusion of the harmonization of laws according to Article 2(5) of the TFEU. 
It means that Member States play a predominant role in this field, which is 
particularly a sensitive area and implies delicate issues of politics and budget 
management. It clearly results from Article 168(7) of the TFEU where it provides that 
“Union action shall respect the responsibilities of the Member States for the definition 
of their health policy and for the organisation and delivery of health services and 
medical care. The responsibilities of the Member States shall include the management 
of health services and medical care and the allocation of the resources assigned to 
them”.  
The EU human rights framework reflects this delicate balance. 
Indeed, in this sense, Article 35 of the Charter of Fundamental Rights of the 
European Union (CFR)
22
 on health care, which embodies principles and programmatic 
                                                             
20 Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal 
protection of biotechnological inventions, available at https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=celex%3A31998L0044 accessed 13 September 2018.  
21 Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting 
standards of quality and safety for the donation, procurement, testing, processing, preservation, storage 
and distribution of human tissues and cells, available at https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=celex%3A32004L0023  accessed 13 September 2018. 
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requirements, provides that “[e]veryone has the right of access to preventive health care 
and the right to benefit from medical treatment under the conditions established by 
national laws and practices”. 
However, it is arguable that some integration between health and environment 
capable of giving adequate consideration to the impact of Anthropocene is a feasible 
route at the EU level, according to paragraph 2 of Article 35 of the CFR, where it 
requires the integration of health policy in “the definition and implementation of all 
Union policies and activities” by ensuring “a high level of health protection”. The 
interrelationship between environment and health can also be found in the Treaties  
framework in Article 191 of TFEU, where it provides that “protecting human health” is 
one of the objectives pursued by Union policy on the environment. 
So far, in practice, the interaction between internal market and health has been a 
more thriving sector for ensuring access to health care.  
Directive 2011/24/EU,
23
 renowned as EU Patients’ Rights Directive, adopted on the 
basis of Articles 114 and 168 TFEU, is a significant example of the promotion of 
mobility and access to cross-border safe and high-quality health care in the EU, and of 
cooperation between Member States.  
According to the Directive, patients are entitled to several rights, primarily the 
reimbursement of actual costs faced. Again, the right to accountability and the right to 
transparency enrich the protection ensured by the Directive which, in this sense, goes 
beyond the views affirmed in the case law of the European Court of Justice (ECJ), that 
had prompted the adoption of this act, from Kohll to Watts case.
24
 It is noteworthy that 
                                                                                                                                                                                  
22 European Union: Council of the European Union, Charter of Fundamental Rights of the European 
Union (2007/C 303/01) (adopted 14 December 2007, entered into force 14 December 2007) C 303/1, 
available at http://www.europarl.europa.eu/charter/pdf/text_en.pdf accessed 13 September 2018. 
23 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the 
application of patients’ rights in cross-border healthcare, available at https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX%3A32011L0024 accessed 13 September 2018. 
24 C-158/96 Raymond Kohll v Union des caisses de maladie (Kohll) [1998] ECR I-1931; Case C-372/04 
The Queen, ex parte Yvonne Watts v Bedford Primary Care Trust and Secretary of State for Health 
[2006] ECR I-4325; Case C-120/95 Nicolas Decker v Caisse de maladie des employés privés (Decker) 
[1998] ECR I-1831. In particular, in these cases, the Court applied the freedom to provide services to 
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the Directive applies to all types of curative health care, including those provided 
privately, outside of public health system. In this respect, it is arguably indicative of the 
fact that the EU’s criteria in relation to resource allocation according to Professor 
Daniels’ classification is “rights”. 
That being said, it should be considered whether this framework might prospectively 
allow a bioethical and a biolegal evolution capable of incorporating scientific progress 
to the point of welcoming transhumanism. 
In this regard, some primary considerations should be made in light of the EU’s 
legal framework from a comprehensive viewpoint. First of all, consistently with the 
Union’s approach to healthcare and to resource allocation informed to “rights”, the 
primary reference is the Charter of Fundamental Rights of the European Union (CFR) 
which offers some reference and some guidance to frame the feasibility of the 
incorporation of advanced biomedical results and technologies within the EU health 
policy. 
The relevant provision is enshrined in Article 3 of the Charter, which provides the 
biolegal founding views of the EU and helps to outline the borders of the practices 
allowed. In particular, Article 3 poses some main principles, namely informed consent, 
the prohibition of making the human body and its parts a source of financial gain and, 
which appear to be particularly helpful for our reflection, the prohibition of cloning for 
reproductive purposes and the prohibition of eugenic practices, “in particular those 
aiming at the selection of persons”. 
Few considerations have to be made about the CFR, to understand the importance of 
the statements it contains from several viewpoints: first of all, because the CFR, in the 
post-Lisbon system, is a primary source of EU law. Therefore, it inspires and informs 
EU legal order and outlines its bioethical frame, thus EU acts have to be adopted in 
compliance with its provisions. 
                                                                                                                                                                                  
health care. In particular, as suggested in scholarship, the Court has adopted a “patient-centred, needs-
based approach” to promote their mobility across EU. DAVIES, G., “The effect of Mrs Watts trip to 
France on the National Health Service”, King’s Law Journal, n° 158, 2007. See SAUTER, W., 
“Harmonisation in healthcare: the EU patients’ rights Directive”, Nederlandse Zorgautoriteit, Hune 2011. 
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Secondly but not less importantly, Article 3 of the CFR of basic importance for the 
understanding of the concept and the scope of human dignity in EU law: as the 
prohibition of human reproductive cloning is enshrined in this provision and not in 
Article 2, on the right to life, in scholarship it was authoritatively held that the 
conception of human dignity embraced by the CFR refers to the born person.
25
 
The consequences from a perspective of transhumanism are remarkable: indeed, it 
may be argued that the EU approach to bioethics does not forbid human germline 
interventions, which is one of the most significant and discussed intervention that might 
be made for helping human nature to express all its potential, to recall Julian Huxley’s 
view. We could argue that it is not prohibited by the principle of human dignity.  
A similar conclusion may be held relying directly on the text of Article 3 of the 
Charter as, when explicitly banning eugenics practices, it only makes reference to the 
selection of persons, whilst no reference is made to human germline modifications. It 
goes without saying that the issue should be considered more in depth to specifically 
outline the feasibility of such interventions from an ethical viewpoint, in particular 
whether we should consider admissible both kinds of human germline alterations, that is 
merely therapeutic modifications or also the enhancing ones. Of course, this would 
require careful debate in the political sphere and, despite the important achievements 
made, primarily the CRISPR technique,
26
 the consequences of these interventions are 
still being tested and assessed by researchers, in both short and long term, basically the 
immunotoxicity and the genotoxicity. However, it is remarkable that in 2015 the United 
Kingdom, still as a Member State of the EU, adopted the Regulation on mitochondrial 
                                                             
25 GARCÍA SAN JOSÉ, D.I., International Bio Law. An International Overview of Developments in 
Human Embryo Research and Experimentation, Murcia, Ediciones Laborum, 2010, pp. 99-100; GARCÍA 
SAN JOSÉ, D. I., “Derecho de la Unión, Investigación embrionaria humana y patentes biológicas”,  
Revista de Derecho Comunitario Europeo, Madrid, n° 41, enero/abril, 2012, pp. 175 ff. 
26 ANDORNO, R., “Can human germline alterations be ethically justified?”, Bioética Forum, n° 10 (2), 
2017, Editorial. In relation to the risks connected to gene therapy, see: NAYAK, S., “Progress and 
prospects: immune responses to viral vectors”, Gene Therapy, n° 17 (3), 2010, pp. 295-304; DAVID, R. 
M., “Viral vectors the road to reducing genotoxicity”, Toxicological Sciences, n° 155 (2,1), 2017, pp. 
315-325. FERRARI, S., ROMEO, G., “La terapia genica”, in CANESTRARI, S., FERRANDO, G., 
MAZZONI, C. M., RODOTÀ, S., ZATTI, P. (Eds.), Trattato di Biodiritto. Il Governo del Corpo, Milano 
Giuffré Editore, 2011, pp. 497-510, 507 ff. 
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 which allows replacing the mother’s mitochondrial DNA 
with that of a donor in case she may transmit a mitochondrial disorder to the child. 
Indirectly, some confirmation of the feasibility of therapeutic interventions may be 
sought in the prohibition of human cloning only for reproductive purposes. This 
statement seems to indirectly allow human cloning for therapeutic purposes and it 
appears all the more relevant since in the last years the international community, both in 
the UN and the UNESCO framework has dedicated huge efforts for the adoption of 
targeted instruments, that led to the UN Declaration on Human Cloning in 2005,
28
 
which posed a blanket ban on both kinds of cloning. It split the international 
community, as consensus exists only on the prohibition of human reproductive cloning, 
as is dealt with more in depth in paragraph 6.
29
 
  However, it cannot be overlooked that the Biotechnology Directive, that addresses 
patentability of biotechnological inventions, seems to adopt a different view and to 
consider contrary to ordre public and morality both human germline alterations and 
human cloning, without making any distinction among therapeutic and reproductive 
purposes with regard to the latter. The ban is set in relation to patentability of inventions 
relying on such practices, consistently with the scope of the Directive. This entails that, 
beyond the scope of application of this act, a cautious approach would be 
recommendable from a general viewpoint.  
                                                             
27 In practice, MRTs allow replacing the mother’s mitochondrial DNA with the one from a woman donor. 
ORCUT, M., “The Unintended Consequence of Congress’s Ban on Designer Babies. The testing of new 
therapies to prevent a debilitating mitochondrial genetic disease in babies has hit a dead end”, MIT 
Technology Review, 26 August 2016, available at https://www.technologyreview.com/s/602219/the-
unintended-consequence-of-congresss-ban-on-designer-babies/ accessed 14 September 2018. CASTRO, 
R., “Mitochondrial replacement therapy: the UK and US regulatory landscapes”, Journal of Law 
Bioscience, n° 3(3), December 2016, pp. 726–735, available at 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570689/ last visited 14 September 2018. For some 
further views see: DI SALVO, D., “The Era Of Genetically-Altered Humans Could Begin This Year”, 
Forbes, 26 January 2014, available at https://www.geneticsandsociety.org/article/era-genetically-altered-
humans-could-begin-year last visited 14 September 2018. 
28 KUPPUSWAMY, C., MACER, D., SERBULEA, M., TOBIN, B., United Nations University – 
Institute of Advanced Studies, Biodiplomacy Programme, “Is Human Reproductive Cloning Inevitable: 
Future Options for UN Governance”, cited above,n . 12. 
29 Ibid. 
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This is clearly an important element that would suggest a careful consideration of 
the possible EU’s approach to transhumanism and its incorporation from a healthcare 
perspective, as a response to the Anthropocene. However, in light of the considerations 
made above, some room for political debate and thorough assessment of these issues 
cannot be excluded, especially as scientific progress is promising and, for example, 
somatic genetic therapy has achieved some important results in the last years. This 
might induce to mitigate the strict approach adopted in 1998 in the wake of the 
sequencing of the human genome, when concerns and instances of protection of the 
human genome were particularly strong. However, the fact that the Biotechnology 
Directive rules out the patentability of the human body, “at any stage in its formation or 
development, including germ cells, and the simple discovery of one of its elements or 
one of its products, including the sequence or partial sequence of a human gene”.  
What may be inferred from the analysis of the EU framework is that feasibility of 
transhumanistic interventions, especially in the sense on which we are focusing here, 
and, in particular, which practices may be viable requires very careful consideration. It 
would be desirable that some further clarification came as to such practices as human 
germline alterations, in particular the therapeutic modifications, and human therapeutic 
cloning, especially because scientific progress is making important steps ahead and the 
possibility to really help humanity to express its potential at its best, in terms of health 
and wellbeing, is becoming a real opportunity and not just an optimistic wish. However, 
such practices as pharmacogenetics or pharmacogenomics and accessibility to 
regenerative medicine, for example, are not precluded by the framework analysed. 
Nevertheless, subsequently it is assessed whether and to which extent their use might be 
considered as a part of health policies of the EU in line with the provision enshrined in 
Article 35 of the CFR, to be translated also into an approach to the Anthropocene’s 
adverse impact on human health. It could also be a way of U of “protecting human 
health” as part of the Union policy on environment according to Article 191 of TFEU. 
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4. TRANSHUMANISM AT THE COUNCIL OF EUROPE 
BETWEEN THE ECHR AND THE OVIEDO CONVENTION 
SYSTEM 
Through the decades, the Council of Europe (COE) has devoted growing attention 
to bioethics, focusing on various thematic areas, namely biomedical research, cloning 
and issues related to human embryo and the foetus, end of life, genetics, transplantation, 
biobanks and psychiatry. The soft law landscape offers many examples of the 
commitment of the COE in this field and, in particular, with regard to equal access to 
health care. Recommendation 2020(2013)
30
 and Resolution 1946(2013)
31
 are 
emblematic in this respect. 
What is more, the COE has been capable to provide the propitious framework for 
the adoption of some international binding instruments in the field of bioethics: the first 
step was the European Convention on Human Rights and Biomedicine (hereinafter “the 
Oviedo Convention”)32 that was followed by its Additional Protocols, which 
respectively deal with the prohibition of cloning human beings, the transplantation of 
organs and tissues of human origin, biomedical research and genetic testing for health 
purposes, and then, in 2011, followed the Council of Europe Convention on the 
counterfeiting of medical products and similar crimes involving threats to public health 
(the “Medicrime Convention”).33 
                                                             
30 Council Of Europe, Parliamentary Assembly, Recommendation 2020(2016) on Equal Access to 
Healthcare, available at  http://assembly.coe.int/nw/xml/XRef/Xref-XML2HTML-
en.asp?fileid=19996&lang=en  accessed 13 September 2018. 





E5OTkx accessed 13 September 2018. 
32 Council of Europe, Convention for the protection of Human Rights and Dignity of the Human Being 
with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine 
(adopted in Oviedo, 4 April 1997, entered into force 1 December 1999) ETS No. 164, P, available at 
https://rm.coe.int/168007cf98 accessed 13 September 2018. 
33 Council of Europe Convention on the counterfeiting of medical products and similar crimes involving 
threats to public health. Reference, opening of the Treaty 28/10/2011, entry into force 01/01/2016, CETS 
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Similarly, environment, climate change and sustainable development have been at 
the top of its Agenda: since the COE Environment Programme
34
 was launched in 1961, 
various treaties were adopted in its framework as, for example, the European Landscape 
Convention,
35
 Convention on the Conservation of European Wildlife and Natural 
Habitats,
36




However, so far, the COE has not tackled the Anthropocene nor its impact on 
human health and the duties of States arising from it. Again, the efforts to introduce the 
right to a healthy environment in the system of the European Convention on Human 
Rights (ECHR) through an additional protocol, were never successful. 
Nevertheless, some interesting indications on the possible evolution of the COE’s 
approach to health in the Anthropocene can be indirectly found in the jurisprudence of 
the European Court of Human Rights (ECtHR) in the field of environment, health rights 
and biolaw, as closer analysis shows. 
Indeed, the ECtHR has proven capable of providing interesting responses when 
environmental issues were raised before it through the “incorporation of environmental 
values” within the scope of application of the European Convention on Human Rights 
(ECHR),
38
 provided that an interrelation with a right protected under the Convention 
                                                                                                                                                                                  
No.211, available at http://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/211 accessed 13 
September 2018. 
34 For wider information about the COE Environment Programme visit this website: 
https://www.coe.int/en/web/compass/environment accessed 14 September 2018. 
35 Council of Europe, European Landscape Convention (adopted by the Committee of Ministers of the 
Council of Europe on 19 July 2000 and opened for signature by its Member States in Florence on 20 
October 2000) available at 
https://rm.coe.int/CoERMPublicCommonSearchServices/DisplayDCTMContent?documentId=09000016
802f80c6 accessed 13 September 2018.  
36 Council of Europe Framework Convention on Convention on the Conservation of European Wildlife 
and Natural Habitats (open for signature 19 September 1979, entered into force 1 June 1982) ETS No. 
104, available at https://www.coe.int/en/web/conventions/full-list/-/conventions/rms/0900001680078aff  
accessed 14 September 2018. 
37 Council of Europe Framework Convention on the Value of Cultural Heritage for 
Society (adopted 27 October 2005, entered into force 1 June 2011) CETS No. 199, available at 
https://www.coe.int/en/web/culture-and-heritage/home accessed 14 September 2018. 
38 Council of Europe, European Convention for the Protection of Human Rights and Fundamental 
Freedoms, as amended by Protocols Nos. 11 and 14 (adopted 4 November 1950, entered into force 3 
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existed. In particular, the right to life and the right to private and family life, 
respectively enshrined in Articles 2 and 8 of the ECHR, and the right to property 
provided in Article 1 of the First Additional Protocol to the ECHR, have offered 
suitable legal bases. A paradigmatic example is offered by the case law of the 
Strasbourg Court on States’ duties in relation to natural disasters, which were connected 
to the adverse effects of climate change in the Budayeva and Kolyadenko v. Russia 
judgments.
39
 In these cases, the Court elaborated a pattern hinged on the standards of 
foreseeability, gravity and mitigability of the threat posed by a natural disaster, as 
means for assessing and affirming State duty to adopt positive measures to protect the 
population affected from the risks connected.
40
 
In a similar fashion, although the ECHR does not expressly provide the right to 
health nor to access to health care, the ECtHR has been capable of providing interesting 
responses to health rights by relying on Article 2 and on Article 3 of the Convention, 
which prohibits torture and inhuman and degrading treatment. In this regard, the Court 
has elaborated a settled approach especially with respect to the right to access to health 
care.  
In particular, the Strasbourg Court has developed the view that the denial of access 
to life-saving emergency treatment amounts to a breach of the substantive limb of 
Article 2 of the ECHR. In the case of Mehmet Şentürk en Bekir Şentür v. Turkey, v. 
Turkey,
41
 various Turkish hospitals refused to admit for treatment a heavily-pregnant 
mother, who subsequently died while travelling in search for the emergency treatment 
                                                                                                                                                                                  
September 1953) ETS 5availbale at https://www.echr.coe.int/Documents/Convention_ENG.pdf accessed 
13 September 2018. 
39 European Court of Human Rights, Budayeva v. Russia, judgment of 20 March 2008, Appl. Nos. 
15339/02, 21166/02, 20058/02, 11673/02 and 15343/02, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22budayeva%22],%22documentcollectionid2%22:[%
22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-85436%22]} accessed 13 
September 2018. 
40HUMPHREYS, S., “Editorial”, Journal of Human Rights and the Environment, n° 7 (1), March 2016, 
pp. 1–6. 
41 European Court of Human Rights, Mehmet Şentürk and Bekir Şentürk v. Turkey, Judgment of 9 April 
2013, Appl. No. 13423/09, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22mehmet%22],%22documentcollectionid2%22:[%2
2GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-118722%22]} accessed 13 
September 2018. 
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needed. The court held that “the authorities of a Contracting State put an individual’s 
life at risk through the denial of health care they have undertaken to make available to 
the population in general” and found a breach of Article 2 of the Convention, since 
States have positive obligations to set up a “regulatory structure […] requiring that 
hospitals, private or public, take appropriate steps to ensure that patients’ lives are 
protected”. In the case, instead, health care system was inadequate and under-resourced. 
A similar pattern was adopted, for example, also in the cases of Asiye Genç v. Turkey, 
Elena Cojocaru v. Romania and Aydoğdu v. Turkey and was taken up again recently in 
the Lopes de Sousa Fernandes v. Portugal.
42
 This suggests that an enhanced approach 
has been adopted in Strasburg in comparison with the Court’s view in the Cyprus v. 
Turkey judgment,
43
 where the it did not go any further than saying that “more than an 
issue may arise” under Article 2 where treatment was systemically denied to 
individuals. 
In the Aleksanyan v. Russia judgment,
44
 the Court held that the denial of access to 
appropriate health care and treatment constituted an inhuman and degrading treatment 
                                                             
42 European Court of Human Rights, Asiye Genç v. Turkey , Judgment of 27 January 2015, Appl. No. 
24109/07, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22Asiye%20Gen%C3%A7%20v.%20Turkey%22],%
22documentcollectionid2%22:[%22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%2
2001-151025%22]} accessed 13 September 2018; European Court of Human Rights, Elena Cojocaru v. 
Romania, Judgment of 22 March 2013, Appl, No. 74114/12, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22elena%20cojocaru%22],%22documentcollectionid
2%22:[%22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-161528%22]} 
accessed 13 September 2018; European Court of Human Rights, Aydoğdu v. Turkey, Judgment of 30 
August 2016, Appl. No. 40448/06, available in French at 
https://hudoc.echr.coe.int/eng#{%22itemid%22:[%22001-166481%22]} accessed 13 September 2018; 
European Court of Human Rights, Lopes de Sousa Fernandes v. Portugal, Appl. No. 56080/13, Judgment 
of 19 December 2017, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22lopes%20de%20sousa%22],%22documentcollectio
nid2%22:[%22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-179556%22]} 
accessed 13 September 2018. 




accessed 13 September 2018. 
44 European Court of Human Rights, Aleksanyan v. Russia, Judgment of 22 December 2008, Appl. No. 
46468/06, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22Aleksanyan%20v.%20Russia%22],%22documentc
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since it “undermined [the applicant’s] dignity and entailed particularly acute hardship, 
causing suffering beyond that inevitably associated with a prison sentence and the 
illnesses he suffered from”. In a similar vein, it is of particular importance that, in the 
same line of jurisprudence, the Court almost recognized the right to ensure continuing 




Again, the ECtHR has developed an important case law in the field of bioethics, 
which encompasses a wide array of issues, ranging from euthanasia and reproductive 
rights to human embryos. For our purposes, it is particularly interesting that the Court 
had chance to assess the issue of accessing to a given medical treatment in the field of 
bioethics and biolaw when abortion rights were at stake. Article 8 of the ECHR, which 
guarantees the right to respect for private and family life, plays a very important role in 
the protection of biorights, and has offered the suitable legal basis for assessing the 
issue of accessibility to given health treatments made available by biomedical progress. 
In particular, the Court has recognized the right to timely access to amniocentesis and 
the right to access to abortion services under the procedural limb of Article 8 of the 
Convention, occasionally in conjunction with Article 3 of the ECHR.  
A significant example is offered by the R.R. v. Poland judgment.
46
 In the Costa and 
Pavan v. Italy case, the Strasbourg Court recognized that the applicants’ exclusion from 
medically assisted reproduction amounted to a disproportionate interference with their 
right to respect for private and family life. Whilst in both R.R. and Costa and Pavan 
                                                                                                                                                                                  
ollectionid2%22:[%22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-
90390%22]} accessed 13 September 2018. 
45 European Court of Human Rights, D. v. the United Kingdom, Judgment of 2 May 1997, Appl. No. 
30240/96, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22d.%20v%20the%20united%20kingdom%22],%22d
ocumentcollectionid2%22:[%22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%2200
1-58035%22]} accessed 13 September 2018. 
46 European Court of Human Rights, R.R. v. Poland, Judgment of 26 May 2011, Appl. No. 27617/04,  
available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22R.R.%22],%22documentcollectionid2%22:[%22G
RANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-104911%22]} last accessed 21 
June 2018.    
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 the Oviedo Convention was taken into account as relevant law, in the 
Glass v. the United Kingdom case
48
 the Court used the Oviedo Convention to assess 
whether “the regulatory framework in place in the United Kingdom is in any way 
inconsistent with the standards [it] la[ys] down […] in the area of consent”. This 
statement is all the more interesting when one considers that the United Kingdom has 
not even signed the Oviedo Convention and that, notwithstanding this, the Convention’s 
standards were applied as parameters to assess the consistency of domestic regulations 
with its bioethical and human rights-based standards.  
What emerges from these considerations is that the ECtHR has proven capable of 
tackling States’ duties in relation to environmental hazards and, specifically, to affirm 
the duty to ensure adequate protection to human life and health with regard to mitigable, 
foreseeable and serious risks. As those that the Anthropocene poses, we could argue, 
and which are likely to affect society in a transversal and massive way, especially the 
most vulnerable subjects including from an economic and social viewpoint. What is 
more, accessibility to healthcare was affirmed by the ECtHR as a right protected under 
the ECHR through remarkable interpretive efforts, and also in relation to several 
biorights. However, so far, the Court has not had the chance to address issues related to 
transhumanism, for example human cloning, to which one the Additional Protocols of 
the Oviedo Convention is dedicated.
49
 When we focus on the legal framework of the 
                                                             
47 European Court of Human Rights, Costa and Pavan v. Italy, Judgment of 28 August 2012, Appl. No. 
54270/10,  available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22costa%22],%22documentcollectionid2%22:[%22G
RANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%22001-112993%22]}  accessed 13 
September 2018. See DI STEFANO, A., “Bio-ethics under Human Rights Scrutiny: Toward a Right to 
Pre-implantation Genetic Testing under the ECHR?”, Strasbourg Observers, 20 September 2012, 
available at https://strasbourgobservers.com/category/cases/costa-and-pavan-v-italy/ last accessed 12 
September 2018, and  DI STFANO, A., “Tutela del corpo femminile  e diritti riproduttivi: biopotere e 
biodiritto nella vicenda italiana in tema di diagnosi preimpianto”, Osservatorio di Diritti Umani, La 
Comunità Internazionale, Fascicolo n° 4, (2013), pp. 745-772. 
48 European Court of Human Rights, Glass v. the United Kingdom, Judgment of 9 March 2004, Appl. No. 
61827/00, available at 
https://hudoc.echr.coe.int/eng#{%22fulltext%22:[%22glass%20v%20the%20united%20kingdom%22],%
22documentcollectionid2%22:[%22GRANDCHAMBER%22,%22CHAMBER%22],%22itemid%22:[%2
2001-61663%22]} accessed 13 September 2018. 
49 Council of Europe, Additional Protocol to the Convention for the Protection of Human Rights and 
Dignity of the Human Being with regard to the Application of Biology and Medicine, on the Prohibition 
of Cloning Human Beings (open for signature 12 January 1998, entered into force 1 March 2001) ETS 
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COE, it appears that some justification can be found in relation to somatic genome 
editing, since Article 13 of the Oviedo Convention provides that any “intervention 
seeking to modify the human genome may only be undertaken for preventive, 
diagnostic or therapeutic purposes”. Otherwise, subsequently Article 13 prohibits 
human germline alterations where it allows genome editing “only if its aim is not to 
introduce any modification in the genome of any descendants”. In this regard, Paragraph 
91 of the Explanatory Report of the Oviedo Convention further specifies the prohibition 
with regard to the gametes, where it states that that “in particular genetic modifications 
of spermatozoa or ova for fertilisation are not allowed”. The objective to protect future 
generations from any distorted use of biology and medicine was a serious concern when 
the Oviedo Convention was adopted, back in 1997 as emerges clearly from the 
Preamble, where it recalls “the need to respect the human being both as an individual 
and as a member of the human species”.  However, it should also be considered that 
now more than twenty years have passed since the Oviedo Convention was drafted and 
that the context of its adoption was peculiar. If, on the one hand, that historical moment 
had raised great expectations on a promising scientific future thanks to the great 
achievements related to the sequencing of the human genome for treating genetic 
diseases, on the other hand scientific progress was not advanced as it is today. Despite 
some techniques and their effects in the short and the long term still require to be 
ascertained fully, the benefits they can bring are undeniable. In this regard, it is 
significant that the Council of Europe itself has issued its Recommendation 2115(2017) 
on “The use of new genetic technologies on human beings”,50 in which it has warned 
                                                                                                                                                                                  
No. 168, available at https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/168 accessed 
13 September 2018. 
50 Council of Europe, Parliamentary Assembly, Recommendation 2115(2017) on “The use of new genetic 
technologies in human beings”, Assembly debate on 12 October 2017 (35th Sitting) (see Doc. 14328, 
report of the Committee on Social Affairs, Health and Sustainable Development, rapporteur: Ms Petra De 
Sutter). Text adopted by the Assembly on 12 October 2017 (35th Sitting), available at 
http://assembly.coe.int/nw/xml/XRef/Xref-XML2HTML-EN.asp?fileid=24228&lang=en last visited 14 
September 2018. Council of Europe, Committee on Bioethics, “Statement on genome editing 
technologies”, 8th Meeting, 1-4 December 2015, available at https://rm.coe.int/168049034a last accessed 
14 July 2018. Further information available at https://www.coe.int/en/web/bioethics/-/gene-
editing?desktop=true last visited 14 September 2018. In particular, it seems interesting to stress that the 
Committee on Bioethics of the COE declared to be “convinced that the Oviedo Convention provides 
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about the “potential abuse for enhancement or eugenic purposes” of the genetic 
engineering techniques. Recommendation 2115(2017) also recalls the risks related to 
human germline alterations in particular, as still some scientific uncertainty as to their 
results exists but also recognizes that some techniques, as the mitochondrial 
replacement therapy (MRT) are practiced, and cited in this regard the experience of the 
United Kingdom. More in detail, it has acknowledged that  “[d]eliberate germ-line 
editing in human beings would cross a line viewed as ethically inviolable”51 but, at the 
same time, it has also recalled that, according to Articles 32 and 28 of the Oviedo 
Convention, this treaty can be amended pursuant to the procedure provided therein by 
the twenty-nine States Parties, considered that “the fundamental questions raised by the 
developments of biology and medicine are the subject of appropriate public discussion 
in the light, in particular, of relevant medical, social, economic, ethical and legal 
implications, and that their possible application is made the subject of appropriate 
consultation”.52 This statement seems to help to suggest a different consideration of the 
moratorium that the COE invokes in relation to human germline alterations; possibly, 
we could argue that this ban might be reconsidered when the results achieved by 
scientific progress become more stable and certain, especially their positive impact on 
human health of present and future generations. This may be particularly true with 
regard to those applications capable of helping human nature to express its potential, as 
the transhumanistic view wished. 
The COE has adopted an express statement on human cloning as well, in the 
Additional Protocol to the Oviedo Convention dedicated to this question. Article 1 
therein contains a blanket ban on human cloning, which possibly should deserve some 
reconsideration in relation to human therapeutic cloning in light of the international 
practice. It is relevant in this regard that in Oregon, in the United States of America, 
important results were achieved for treating successfully a child affected by a serious 
                                                                                                                                                                                  
principles that could be used as reference for the debate called for at international level on the 
fundamental questions raised by these recent technological developments”. 
51 Council of Europe, Parliamentary Assembly, Recommendation 2115(2017) on “The use of new genetic 
technologies in human beings”, cited above n. 50, para. 3. 
52 Ibid.  
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 Therefore, despite we still have to wait for the scientific applications 
considered to ascertain their impact on human health, especially with respect to human 
germline modifications, these techniques are promising and some reconsideration 
someday may become duly and, possibly, also desirable. This is why it seems important 
to anticipate that moment and to provide human rights consistent responses the soonest, 
which also seems in line with the statement contained in the Explanatory Report of the 
Oviedo Convention that “the developments in medicine and biology […] should be used 
only for the benefit of present and future generations and not be diverted in ways that 
run counter to their proper objective”, as scientific progress has to serve always the 
“benefits of progress to the whole of mankind”.54 
Given the delicate nature of these applications, we should not let law lag behind 




5. THE EMERGENCE OF AN INTERNATIONALLY SHARED 
CORE CONCEPTION OF THE RIGHT TO HEALTH  
 
5.1  An overview of the universal and regional landscape  
Definition of the more specific content of the right to health in the framework of the 
EU and of the COE for the prospective approach to the era of the Anthropocene cannot 
prescind from the landscape of international law. 
                                                             
53 POLLACK, A., “Cloning Is Used to Create Embryonic Stem Cells”, The New York Times, 15 May 
2013, available at https://www.nytimes.com/2013/05/16/science/scientists-use-cloning-to-create-
embryonic-stem-cells.html accessed 14 September 2018. 
54 Explanatory Report to Convention for the protection of Human Rights and Dignity of the Human Being 
with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine, 
Oviedo, 4 April 1997, ETS No. 164, Paragraph 15. 
55 GARCÍA SAN JOSÉ, D.I., International Bio Law. An International Overview of Developments in 
Human Embryo Research and Experimentation, cited above n. 25, pp. 149, 164, 179, 189, 192. 
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In this respect, as authoritatively highlighted in scholarship,
56
 an opinio iuris has 
emerged at the international level, as closer analysis of conventional international law 
shows. 
At the global level, under Article 12 of the International Covenant on Economic, 
Social and Cultural Rights (ICESCR), “[e]very human being is entitled to the enjoyment 
of the highest attainable standard of health conducive to living a life in dignity” since 
“[h]ealth is a fundamental human right indispensable for the exercise of other human 
rights”, as the Committee on Economic, Social and Cultural Rights has clarified in 
General Comment No. 14 on “The Right to the Highest Attainable Standard of Health”. 
Practical enforcement is defined by the “4-A scheme”, that hinges on availability, 
accessibility, acceptability and adaptability - which turns into quality when health is at 
stake. Substantially, it requires that health services, goods and facilities, be made 
available in sufficient quantity and be made accessible without discrimination, 
physically, economically and informationally. 
At the regional level, the Inter-American Court of Human Rights, in connection with 
human dignity and the conception of dignified life, the Court has affirmed the right to 
access to the highest attainable standards of health, including health care and assistance, 
treatment and medication, without any discrimination. The decisions of the Court in the 
cases of the Yakye Axa Indigenous Community v. Paraguay,
57
 Ximenes-Lopes v. 
Brazil,
58
 Albán Cornejo et al. V. Ecuador
59
 and Ver-Vera et al.  v. Ecuador
60
 are some 
paradigmatic examples. What is more, the Court had the chance to apply this view in 
                                                             
56 GARCÍA SAN JOSÉ, D. I., Crisis económica, vulnerabilidad multidimensional y cambio climático: la 
“tormenta perfecta” para el derecho a la salud en europa, Bioderecho.es, Estudios de Vulnerabilidad, n. 
5, 2017, available at http://revistas.um.es/bioderecho/article/view/290821 accessed 13 September 2018. 
57 Inter-American Court of Human Rights [IACtHR], Case of the Yakye Axa Indigenous Community v 
Paraguay, Merits, Reparations and Costs, IACHR Series C No .125, IHRL 1509 (IACHR 2005), 
Judgment of 17 June 2005. 
58 Inter-American Court of Human Rights [IACtHR], Case of Ximenes-Lopes v. Brazil, Merits, 
Reparations and Costs, IACHR Series C No. 149, IHRL 1533 (IACHR 2006), Judgment of 4 July 2006.  
59 Inter-American Court of Human Rights, Case of Albán-Cornejo et al. v. Ecuador, Interpretation of the 
Judgment on the Merits, Reparations and Costs, IACHR Series C No.  171, Judgment of 5 August 5, 2008 
60 Inter-American Court of Human Rights [IACtHR], Case of Ver-Vera et al.  v. Ecuador, Preliminary 
Objection, Merits, Reparations and Costs, Series C No. 226, Judgement of 19 May 2011. 
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the field of bioethics in the case of Artavia Murillo et al. v. Costa Rica,
61
 where it held 
that the prohibition of in-vitro fertilization set by Costa Rica breached the right to 
privacy, the right to personal liberty, the right to physical, mental and moral integrity 
and the right to found a family protected under the ACHR and recognized the right to 
access to given biomedical techniques, namely in-vitro fertilization, under the ACHR, 
by establishing that the rights to private life and to personal integrity are also directly 
and immediately linked to health care. 
With reference to the allocation of resources, Article 2 of the ICESCR and Article 
26 of the American Convention on Human Rights provide the “progressive realization” 
clause, which otherwise is not contemplated by the African Charter on Human and 
Peoples’ Rights that, in its Article 16 enshrines the “right to enjoy the best attainable 
state of physical and mental health”. Moreover, the African Commission on Human and 
Peoples’ Rights has provided an important reading of the right to health in connection 
of environmental degradation due to oil activities in the Social and Economic Rights 




This conception of the right to health echoes the Constitution of the World Health 
Organization (WHO),
63
 that defines “the highest attainable standard of health as a 
fundamental right of every human being”, and the UNESCO Universal Declaration on 
                                                             
61 Inter-American Court of Human Rights, Case of Artavia Murillo et al. ("In vitro fertilization") v. Costa 
Rica, Preliminary Objections, Merits, Reparations and Costs, Series C No. 257, Judgment of 28 
November 2012. For a wider analysis of the judgment see: CHIA, E. A., CONTRERAS, P.,  “Análisis de 
la Sentencia Artavia Murillo y Otros (“Fecundación In Vitro”) vs. Costa Rica de la Corte Interamericana 
de Derechos Humanos”, Estudios Constitucionales, vol. 12, n° 1, (2014), pp. 567-585. Centro de Estudios 
Constitucionales de Chile. Santiago, Chile. Also see: Centro de Bioética, ADMIN, “Para la Corte 
Interamericana, el embrión no es persona”, Centro de Bioética – Persona y Familia, 21 December 2012, 
available at http://centrodebioetica.org/2012/12/para-la-corte-interamericana-el-embrion-no-es-persona/ 
accessed 13 September 2018. 
62 155/96 Social and Economic Rights Action Center (SERAC) and Center for Economic and Social 
Rights (CESR) / Nigeria, available at http://www.achpr.org/communications/decision/155.96/ last visited 
14 September 2018. See: KIAPI, S., “Interpreting the right to health under the African Charter”, in East 
African Journal of Peace and Human Rights, n° 11(1), 2005, pp. 1-20, and OKAFOR, O. C., “A regional 
perspective: article 22 of the African Charter on Human and Peoples’ Rights, in Realizing the Right to 
Development”, Essays in Commemoration of 25 Years of the United Nations Declaration on the Right to 
Development, United Nations, 31 December 2013, pp. 373-384. 
63 Constitution of the World Health Organization. Geneva: World Health Organization; 1948. 
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Bioethics and Human Rights.
64
 The latter is a particularly interesting reference, 
especially for two reasons. First, because in its Part II it enshrines some substantial 
principles of bioethics, among which access to healthcare and essential medicines 
(Article 14) by connecting “social responsibility and health”. Then, but not less 
important, because although non-binding it has the nature of a legal instrument, since it 
was adopted in the framework of an intergovernmental organization and therefore it 
enhances the view that an opinio iuris has progressively emerged as to a generalized, 
shared conception of the right to health.  
5.2 Some considerations on the core conception of the right to health 
That being said, we should question whether this core conception of health and in 
particular the application of the notion of highest attainable standards may be 
considered from an evolutionary viewpoint, that is, in particular, whether its scope 
should be considered in a flexible and farsighted way, capable of incorporating the 
advances of scientific progress and the purposeful reflections elaborated in the 
philosophical debate. 
Besides the capacity of the international jurisprudence considered above to provide 
an advanced reading of States’ duties under the right to health, four our purposes it is 
indicative that the Committee of Economic, Social and Cultural Rights has expressly 
clarified in its General Comment n. 14(2000)
65
 that the right to health has not to be 
intended as the right to be healthy but it entails, along with other components, the 
creation of appropriate environmental conditions. In this regard, an interconnection 
emerges between human health and environmental conditions, among which those 
impacted by the Anthropocene may be included. In order to further clarify the scope of 
the right to health and theorize how it may be intended in relation to advanced scientific 
                                                             
64 UN Educational, Scientific and Cultural Organisation (UNESCO), Universal Declaration on the Human 
Genome and Human Rights, 11 November 1997, available at http://portal.unesco.org/en/ev.php-
URL_ID=31058&URL_DO=DO_TOPIC&URL_SECTION=201.html accessed 14 September 2018. 
65 UN Committee on Economic, Social and Cultural Rights (CESCR), General Comment No. 14: The 
Right to the Highest Attainable Standard of Health (Art. 12 of the Covenant), 11 August 2000, 
E/C.12/2000/4, available at: http://www.refworld.org/docid/4538838d0.html accessed 17 September 
2018. 
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techniques as a means for coping with the adverse impact of the Anthropocene, it would 
be helpful to rely further on the interpretive guidance provided the Human Rights 
Committee. Despite the General Comment No. 14(2000) does not expressly recall 
scientific progress, it contains some interesting reference with regard to the standard of 
quality, where it requires that “health facilities, goods and services must also be 
scientifically and medically appropriate and of good quality”.66 We could argue that 
advanced therapeutic means made available by scientific progress maybe encompassed 
in the notion of quality. What is more, it is indicative that Paragraph 13 of General 
Comment 14(2000) clarifies that the specific measures contemplated at Paragraph 12.2, 
concerning the right to maternal, child and reproductive health, the right to healthy 
natural and workplace environments and the right to prevention, treatment and control 
of diseases are not exhaustive and other measures, as those suggested, may be 
considered for implementing the right to health and ensuring the enjoyment of the 
highest attainable standards of health. 
Moreover, some additional confirmation may be sought in the more recent General 
Comment No. 22(2016),
67
 on the right to sexual and reproductive health. Indeed, this 
reference provides more specific and explicit guidance with regard to the standard of 
“quality”. In particular, it is significant that at Paragraph 21 it provides that “[t]he 
failure or refusal to incorporate technological advances and innovations in the provision 
of sexual and reproductive health services, such as medication for abortion, assisted 
reproductive technologies and advances in the treatment of HIV and AIDS, jeopardizes 
the quality of care”. According to a comprehensive consideration of both General 
Comments considered and since sexual and reproductive health is encompassed in the 
core conception of the right to health emerged in international law, we could argue that 
                                                             
66 Ibid, para. 12(d).  
67 UN Committee on Economic, Social and Cultural Rights, General comment No. 22 (2016) on the right 
to sexual and reproductive health (article 12 of the International Covenant on Economic, Social and 
Cultural Rights), 2 May 2016, E/C.12/GC/22, available at  
http://docstore.ohchr.org/SelfServices/FilesHandler.ashx?enc=4slQ6QSmlBEDzFEovLCuW1a0Szab0oX
TdImnsJZZVQfQejF41Tob4CvIjeTiAP6sGFQktiae1vlbbOAekmaOwDOWsUe7N8TLm%2BP3HJPzxjH
ySkUoHMavD%2Fpyfcp3Ylzg accessed 14 September 2018. 
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access to the advanced techniques made available by scientific progress represents a 
component of the right to health and to the enjoyment of its highest attainable standards. 
6. SOME REFLECTIONS ON THE POSSIBLE 
UNDERSTANDING OF TRANSHUMANISTIC 
INTERVENTIONS ON THE HUMAN BODY 
However, we should question more specifically which advanced techniques could 
be included in this notion and which purposes could be consistently pursued.  
The conception of transhumanism, in fact, is quite wide, as well the interventions 
and transformations that could be made on the human body from this perspective, 
including for coping with the adverse impact of the Anthropocene. Therefore, some 
guidance to define which interventions may be feasible should be sought, from a wide 
viewpoint, in the conception of genetic identity and genetic integrity, which helps to 
clarify how the human body might be modified, with regard to both the individual and 
to the human species. This may be argued because transhumanism entails to rethink the 
human body to some extent. However, also in line with the view advanced by Julian 
Huxley, admissible interventions are those that help human nature to express its 
potentiality, as Dante Alighieri said in the Divina Commedia, a form of “trasumanar”,68 
that, consistently with the views of Julian Huxley, transcends human nature without 
getting at odds with it. A “trasumanar” that is not confined to some individuals, but 
which is intended to achieve the whole species and future generations. Which would be 
necessary, it can be observed, if we consider to conceive transhumanistic solutions, in 
this sense, as a strategic means to be scheduled by States as a response to the 
Anthropocene and the threats it poses to human health. 
In this regard, the views expressed in scholarship can be very conflicting: they 
are often described through the dichotomy between bioconservatives and transhumists. 
However, beyond any classification, in practice at the extremes, we find those who 
                                                             
68 As stressed by RODOTÀ, S., Il diritto di avere diritti, cited above n. 13, p. 365. ALIGHIERI, D., 
Divina Commedia, Canto I, 70-71. “Trasumanar significar per verba | non si poria”: Dante Alighieri 
describes as “trasumanar” the transition to Paradise, through the overcoming of his human condition. 
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reject the idea that human nature, intended in relation to Darwinian evolution, can be 
altered. In this sense, Hans Jonas supported the integrity of the human species, that is 
inalterable.
69
  In a similar vein, it was argued that any modification of the genetic 
identity of the human being would even amount to a crime against humanity, as was 
paradigmatically claimed by George Annas.
70
 And in this regard any modification 
should be rejected, even those aimed at improving human health through human 
germline alterations of therapeutic nature, not just those aimed at enhancement. On the 
contrary some other scholars have supported a restricted conception of genetic identity, 
stressing that it would encompass only core traits of the person. Therefore, any 
alteration concerning the pathological traits and their elimination would not actually 
affect the genetic identity of the individual and would be admissible. Moreover, it has 
also been stressed that genetic identity should not be overlapped with genetic integrity 
that is the right to a non-modified genetic heritage. However, with reference to this 
aspect it was stressed that “[t]he association of the right to genetic integrity […] with 
the right to genetic identity […]focuses solely upon the perils of the [genetic 
manipulation] without considering the potential benefits that can be derived from 
human genetic interventions” and that “[t]he right to genetic identity, therefore, should 
both foresee the integrity but also the changeability of one’s genetic architecture.”71 
                                                             
69 JONAS, H., The Imperative of Reponsibility - In Search of an Ethics for the Technological Age, 
Chicago, London, The University of Chicago Press, 1984. Also see: MORRIS, T., Hans Jonas's Ethic of 
Responsibility: From Ontology to Ecology, Albany, State University of New York Press, 2013. Also see: 
HABERMAS, J., Il futuro della natura umana. I rischi di una genetica liberale, Torino, Einaudi, 2002. 
70 ANNAS, G., ANDREWS, L., ISASI, R., “Protecting the endangered human: toward an international 
treaty prohibiting cloning and inheritable alterations”, American Journal of Law and Medicine, n° 28 (2-
3), 2002, pp. 151-178. 
71 The whole quotation reads: “[It] is important to understand that not every intervention on the human 
genome aimed at modifying the germline necessarily equates to a eugenic practice. Therefore, it is more 
appropriate to follow the drafting example of the Charter of Fundamental Rights of the European Union’s 
art 3, “Right to the integrity of the person”, which unlike the Oviedo Convention, does not enshrine any 
general prohibition of germline genetic modifications. Article 3, refers instead to the prohibition of 
eugenic practices (in particular those aiming at the selection of persons) specifically and to the 
reproductive cloning of human beings (art 3.2). Contrary to the initiatives in the 1980s and 1990s led by 
European institutions, the right to genetic integrity is no longer formulated in terms of a general right to a 
non-modified genetic heritage or as an equivalent of a right to genetic identity. The association of the 
right to genetic integrity (and, subsequently, the right to a non-modified genetic heritage) with the right to 
genetic identity constitutes an old fashioned, narrow and detrimental view of human genetic 
manipulation, which focuses solely upon the perils of the latter without considering the potential benefits 
that can be derived from human genetic interventions. The right to genetic identity, therefore, should both 
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This seems particularly true when a given intervention of genome editing or any 
modification of the human body prescinding from genetics is practiced for therapeutic 
purposes and, in some way, in order to restore previous better or optimal health 
conditions. 
That being said, it may be argued that the basic point seems to be precisely the 
dichotomy between any intervention that is made on the human body, either genetically 
or not, for therapeutic purposes or for enhancement purposes. 
As Professor Stefano Rodotà stressed, we should be careful and make the 




A particular focus is made here primarily and especially on genetic interventions, as 
they are suggested as, possibly, the more appropriate and targeted approach since the 
adverse impact of the Anthropocene are likely to affect individuals and the whole 
human species epigenetically. In this regard several distinctions have to be made, as 
genetic interventions may be of two kinds: on the one hand, they can affect the human 
germline and, as such, they are transmissible to future generations; on the other hand, 
they can concern somatic cells, therefore the only affect the individual on which the 
modifications are made. Another important and highly discussed practice is human 
cloning, which can be of two different types, either reproductive, which entails the 
creation of a human embryo through the technique of nuclear transfer and the 
subsequent implantation in the uterus, or therapeutic, which consists in the creation of 
an embryo that, differently from what happens in human reproductive cloning is not 
implanted in the uterus but, otherwise, is used for obtaining of embryonic cells, that are 
pluripotent, that are destined to be used for somatic therapy or for, example, for 
                                                                                                                                                                                  
foresee the integrity but also the changeability of one’s genetic architecture: the right to personal identity 
may perfectly encompass the right to individual genetic modification.”  GOMES DE ANDRADE, N. N., 
“Human Genetic Manipulation and the Right to Identity: the Contradictions of Human Rights Law in 
Regulating the Human Genome”, SCRIPTed, n° 7 (3), December 2010, pp. 429-452, 437. Also see, in 
particular, pp. 432-433. Moreover, the individual genetic identity and integrity should not be overlapped 
with the genetic identity and integrity of the species. 
72 RODOTÀ, S., Il diritto di avere diritti, cited above n. 13, p. 354. 
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regenerative medicine. The two practices considered are particularly relevant, as the 
international community has expressed its consensus about their prohibition, that was 
also enshrined in two outstanding international law sources, namely Article 11 of the 
UNESCO Universal Declaration on Human Genome and Human Rights
73
 and Article 
13 of the European Convention on Biomedicine and Biorights and Article 1 of its 
Additional Protocol on Human Cloning,
74
 which were mentioned previously in 
Paragraph 4. However, the international landscape now appears to be in progress and it 
may be argued that some appropriate reconsideration should be made. In light of the 
statements issued between 2015 and 2017, the UNESCO and the COE themselves 
seemed to have shifted to a position of prohibition to a position of stand-by until the 
outcomes scientifically achievable are clarified, with particular regard to human 
germline alterations.
75
 This was somehow unavoidable since China conducted a very 
interesting experimentation– although not as successful as wished – on Beta-
Thalassemia by relying on human germline alterations in 2015
76
 and, in the same year, 
                                                             
73 UN Educational, Scientific and Cultural Organisation (UNESCO), Universal Declaration on the Human 
Genome and Human Rights, 11 November 1997, Adopted unanimously and by acclamation by the 
General Conference of UNESCO at its 29th session on 11 November 1997, available at 
http://portal.unesco.org/en/ev.php-URL_ID=13177&URL_DO=DO_TOPIC&URL_SECTION=201.html 
last accessed 13 September 2018. 
74 Council of Europe, Convention for the protection of Human Rights and Dignity of the Human Being 
with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine, 
cited above n. 32 and Council of Europe, Additional Protocol to the Convention for the Protection of 
Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine, 
on the Prohibition of Cloning Human Beings, cited above, n. 49. 
75 UNESCO, International Bioethics Committee, Report of the IBC on Updating Its Reflection on Human 
Genome and Human Rights, SHS/YES/IBC-22/15/2 REV.2, Paris, 2 October 2015, available at  
http://unesdoc.unesco.org/images/0023/002332/233258E.pdf last accessed 14 September 2018. Council 
of Europe, Parliamentary Assembly, Recommendation 2115(2017) on “The use of new genetic 
technologies in human beings” and Council of Europe, Committee on Bioethics, “Statement on genome 
editing technologies”, both cited above n. 50.  
76 CYRANOSKI, D., REARDON, S., “Chinese scientists genetically modify human embryos. Rumours 
of germline modification prove true — and look set to reignite an ethical debate”, Nature, 22 April 2005, 
available at https://www.nature.com/news/chinese-scientists-genetically-modify-human-embryos-1.17378 
last visited 14 September 2018. Also see: BROWN, H.,  “World’s first genetically modified human 
embryo raises ethical concerns”, The Conversation, 27 April 2015, available at 
https://theconversation.com/worlds-first-genetically-modified-human-embryo-raises-ethical-concerns-
40766 accessed September 2018. for deeper analysis on further evolution, see: CYRANOSKI, D., 
“Chinese scientists fix genetic disorder in cloned human embryos. A method for precisely editing genes 
in human embryos hints at a cure for a blood disease”, Nature, 2 October 2017, available at  
https://www.nature.com/news/chinese-scientists-fix-genetic-disorder-in-cloned-human-embryos-1.22694 
accessed 14 September 2018. 
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the United Kingdom has adopted its Regulation that allows mitochondrial replacement 
therapy (MRTs).
77
 Similarly the debate is quite intense also with regard to human 
cloning. Once again, the distinction among the purposes pursued turns out to be of basic 
importance: in fact, a divergence of views exists with respect to human therapeutic 
cloning; whilst some countries have already adopted targeted regulation that allows it 
domestically, other States wish for a blanket ban on human cloning that would make no 
distinction between therapeutic and reproductive purposes. The clash among the 
pluralistic States’ positions has practically paralyzed the possibility to adopt a treaty on 
the issue, in particular aimed at forbidding human reproductive cloning. The experience 
of the United Nations in 2005 is particularly emblematic: the goal originally pursued, 
that is adopting an international convention on the prohibition, had to be changed as the 
negotiation came to an impasse. The outcome achieved is the UN Declaration on 
Human Cloning; of course, as a soft law tool, it has a moral and political persuasiveness 
on States, but of it is not a binding instrument. What is more, it is significant to notice 
that the international community appeared to be split when it came to vote the approval 
of the Declaration: 84 States voted in favour, whilst 34 voted against and 37 abstained.
78
 
The divergence of views also accounted for the impossibility to adopt a convention 
when the UNESCO tried this route again several years later on two occasions, the first 
time in 2008 and then in 2014.
79
 The  fact that human therapeutic cloning was 
successfully experimented in the United States in 2013
80
 gave an impulse to the 
UNESCO’s engagement but was not enough for helping to overcome the divergences.  
                                                             
77 In this regard is of little help to stress that MRTs would concern mitochondrial and not nuclear DNA, 
as in the end the modifications made would affect the human germline, as was argued in order to provide 
a justification on the admissibility of this practice. See: SCOTT, R., WILKINSON, S., “Germline Genetic 
Modification and Identity: the Mitochondrial and Nuclear Genomes”, Oxford Journal of Legal Studies, n° 
37 (4), 2017, pp. 886–915. In this regard, with respect to the view of the Council of Europe, see Council 
of Europe, Recommendation 2115 (2017), cited above n. 50, para. 2. 
78 KUPPUSWAMY, C., MACER, D., SERBULEA, M., TOBIN, B., United Nations University – 
Institute of Advanced Studies, Biodiplomacy Programme, “Is Human Reproductive Cloning Inevitable: 
Future Options for UN Governance”, cited above n. 12. 
79 Ibid. 
80 POLLACK, A., “Cloning Is Used to Create Embryonic Stem Cells”, cited above n. 53. 
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These considerations are helpful to highlight that the distinction between therapeutic 
interventions and alterations made for other purposes is the of key importance for 
clarifying which practices may be arguably allowed. 
The debate in scholarship seems to have basically embraced this perspective. In this 
respect, it could be helpful to recall that view which was emblematically upheld by John 
Harris
81
 and would allow human germline alterations for therapeutic purposes assuming 
that a duty exists to improve the health of present and future generations if the necessary 
means and techniques are available. In this respect Harris stressed that, nonetheless, any 
therapeutic intervention also implies some enhancement, as it determines an 
improvement of human health. However, it is interesting to consider that the criterion of 
“normality”82 suggested in scholarship as a means for distinguishing feasible practices 
from the forbidden ones, might be helpful for our purposes. This would pave the way to 
the acceptability of any alteration of the human body that is capable of creating a 
situation of “normality” that the subject affected never enjoyed or, otherwise, to restore 
a condition of “lost” normality. In practice, it is not always easy to distinguish 
therapeutic from enhancement interventions. For example, it was suggested that the 
criterion of “normality” would help to identify “therapeutic” modifications of the 
                                                             
81 HARRIS, J., Enhancing evolution. The ethical case for making people better, Princeton, Princeton 
University Press, 2007; also see: FARALLI, C., ZULLO, S., “Terapia genica e diritti della persona”, in 
CANESTRARI, S., FERRANDO, G., MAZZONI, C. M., RODOTÀ, S., ZATTI, P. (Eds.), Trattato di 
Biodiritto. Il Governo del Corpo, cited above n. 26, pp. 511-529, 526 ff. 
82 RODOTÀ, S., Il diritto di avere diritti, cited above n. 13, pp. 348 ff.  It is interesting to recall here how 
the standard of normality was taken into account in the context of sport competitions. Int his regard the 
case of Oscar Pistorius is emblematic. In particular, the International Association of Athletics decided that 
he was not eligible for Olympic qualifying events: as a double amputee sprinter, his carbon fiber 
prosthetics “should [have been] considered as technical aids which [gave] him an advantage over other 
athletes not using them”. However, the decision was overturned by the Court of Arbitration for Sport of 
Lausanne that it was not proven that Oscar Pistorius got an advantage from the equipment, therefore he 
had to be considered eligible for participating in Olympic qualifying events. In this regard, his condition 
was considered not to exceed what we could call the normal standards for eligibility. A different issue 
that, nevertheless, seems interesting to recall here, is genetic doping, which is defined by the Anti-Doping 
Agency as “the non-therapeutic uses of genes, genetic elements and/or cells that have the capacity to 
enhance athletic performance” and in 2003, for the first time, was included in the Prohibited List – 
International Standard, related to the World Anti-Doping Code, of the World Anti-Doping Agency of the 
UNESCO. The List is an Annex of the UNESCO International Convention against Doping in Sports.  
See: VERDUGO GUZMÁN, S. I., “El dopaje genético y la manipulación de genes en el deporte”, IUS ET 
SCIENTIA, n° 3 (1), 2017, pp. 227-234; UNAL, M., OZER UNAL, D., “Gene doping in sports”, Sports  
Medicine, n° 34 (6), 2004, pp. 357-362. 
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human genome insofar as they entail “corrective” interventions, in order to prevent the 
onset of genetic diseases. Enhancing alterations, instead, would be those intended to 
bring about an improvement of some traits of the subject treated, even when no 
pathological exigency required it as, for instance, modifications aimed at increasing the 
intellectual capacity of an individual. Despite the difficulties that may emerge, this 
standard seems helpful, and it would also help to theorize an ethical justification to such 
practices as personalized medicine, pharmacogenetics or pharmacogenomics and 
regenerative medicine. 
Such practices have a different impact on the human being than genome editing and 
the legal issues they raise are different from those posed by human therapeutic cloning. 
In particular, these practices do not entail any alteration of the genetic identity, 
otherwise they rely on it in order to advance customized diagnostic and therapeutic 
responses. More than the genetic integrity of the subjects concerned, the protection of 
the genetic information and related issues of non-discrimination on a genetic basis are at 
stake. Nevertheless, as anticipated, the above-mentioned conception of genetic identity 
is relevant in this respect too for providing justification: personalized medicine, indeed, 
consists in providing customized medical care according to the genetic makeup of a 
specific patient. Its conceptual elaboration dates back to the early twentieth century, 
when the English doctor Archibald Garrod theorized a “chemical individuality”,83 
arguing that an interconnection existed between metabolic alterations and congenital 
and inheritable alterations, by making reference, thus, to genetic susceptibility, that is a 
conception of basic importance. The conception of individualized medicine was taken 
up in the 1940s by Beadle and Tatum, that succeeded to highlight the role of enzymes in 
the metabolic processes connected to the gens that codify them.
84
 In this way, it was 
defined the genetic variability among individuals which is of basic importance from 
                                                             
83 DEL BARRIO SEOANE, J., “Medicina individualizada”, Enciclopedia de Bioderecho y Bioética, 
available at https://enciclopedia-bioderecho.com/voces/212 accessed 13 September 2018. GARROD, A. 
E., “The incidence of alkaptonuria: a study in chemical individuality”, Lancet, vol. II, 1902, pp. 1616-
1620. 
84 DEL BARRIO SEOANE, J., “Medicina individualizada”, cited above n. 83; JAIN, K.K., Textbook of 
Personalized Medicine, New York, Heidelberg, Dordrecht, London, Humana Press, 2015.  
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several viewpoints. On the one hand, it has constituted the basis for pharmacogenetics 
or pharmacogenomics,
85
 a therapeutic approach that relies on the interplay between the 
peculiar genetic makeup of each individual and the connected specific drug response. It 
is likely that soon, thanks to the relentless scientific progress, it will be possible to 
sequence the personal genome, entirely and in real time, a possibility that goes well 
beyond the diagnostic helpfulness of genetic testing.
86
 If, on the one hand, such 
achievements are of fundamental importance for the individual therapeutic success, on 
the other hand they pose a threat to social justice, equality and genetic discrimination 
and stigmatization. For example, it might lead to the “selection” of the diseases to be 
treated, giving priority to the disorders that are prevalent in the population. What is 
more, pharmacogenomics and pharmacogenetics may raise issues of protection and 
confidentiality of the genetic information
87
 and may lead to discriminations and 
stigmatisation that might affect the subject specifically concerned, for example in the 
labour market or in relation to insurance issues. This is why an ethical and human 
rights-consistent approach is of basic importance, and clearly requires adequate and 
equitable allocation of the resources available as well, since access to these technologies 
                                                             
85 RUÍZ-CANELA LÓPEZ, M., “Farmacogenética y farmacogenómica”, Enciclopedia de Bioderecho y 
Bioética, available at https://enciclopedia-bioderecho.com/voces/155 accessed 13 September 2018. 
GINSBURG, G. S., WILLARD, H. F., Genomics and Personalized Medicine, Amsterdam, Boston, 
Heidelberg, London, New York, Oxford, Paris, San Diego, San Francisco, Sidney, Tokyo, Elsevier, Vol. 
1 and 2, 2012. LÓPEZ-LÓPEZ, M., GUERRERO-CAMACHO, J. L., FAMILIAR-LÓPEZ, I. M., JUNG-
COOK, H., CORONA-VÁZQUEZ, T., ALONSO-VILATELA, M. E., “Pharmacogenomics: the quest for 
individualized therapy”, Revista de Neurologia, n° 39 (11), 2004, pp. 1063-1071. There are still different 
views in scholarship about the two expressions “pharmacogenetics” and “pharmacogenomics”; however, 
despite and beyond this disagreement, this study shares the view according to which “pharmacogenetics” 
refers to a specific gene or group of genes, whilst “pharmacogenomics” refers to the analysis of 
articulated processes that might come to affect the whole genome.  The development of the study on 
pharmacogenetics and pharmacogenomics received a great impulse from the Human Genome Project and 
especially by the whole sequencing of the human genome. 
86 DAGNA BRICARELLI, F., “I Test Genetici”, in CANESTRARI, S., FERRANDO, G., MAZZONI, C. 
M., RODOTÀ, S., ZATTI, P. (Eds.), Trattato di Biodiritto. Il Governo del Corpo, cited above n. 26, pp. 
371-387; ANNECCA, M. T., “Test Genetici e Diritti della Persona”, in CANESTRARI, S., FERRANDO, 
G., MAZZONI, C. M., RODOTÀ, S., ZATTI, P. (Eds.), Trattato di Biodiritto. Il Governo del Corpo, 
cited above n. 26, pp. 389-422. 
87 RUÍZ-CANELA LÓPEZ, M., “Farmacogenética y farmacogenómica” and GINSBURG, G. S., 
WILLARD, H. F., Genomics and Personalized Medicine, both cited above n. 85. MALPAS, P. J., “Is 
genetic information relevantly different from other kinds of non-genetic information in the life insurance 
context?”, Journal of Medical Ethics, n° 34, 2008, pp. 548-551. NEBERT D. W., "Pharmacogenetics and 
pharmacogenomics: why is this relevant to the clinical geneticist?”, Clinal Genetics, n° 56 (4),1999, pp. 
247-258. 
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is expensive. However, from a perspective of personalized medicine and 
transhumanism, regenerative medicine appears even more relevant, due to its impact on 
the physical integrity of the subject treated for the goal of regenerating cells and tissues. 
In fact, cellular regenerative medicine
88
 entails specific practices that require a direct 
“manipulation” of the human body, for example implantation of cell preparations, 
systemic infusion or a combination of therapy with mesenchymal cells and genetic 
therapy. It appears clear that it would be a helpful means for coping with the 
deterioration of the human body that exposure to Anthropocene’s adverse effects might 
cause which is even more interesting since the relevance of the impact of the 
environmental factors in triggering genetic disorders has proven stronger than we 
thought. And this is of basic importance for finding a way for treating polygenic 
disorders as, for instance, some types of cancer, diabetes and psychiatric and 
cardiovascular diseases.
89
 What is more, cellular regenerative medicine may offer an 
alternative to human therapeutic cloning, without raising the same ethical concerns with 
regard to the use of human embryos – although create by the technique of nuclear 
transfer – and the related moral questions concerning human life. Another important 
branch of regenerative medicine is represented by bioprinting of tissues and organs for 
transplantation, a technique which has so far been successfully used all over the world. 
In this regard are eloquent evidence of the promising viable application of 
bioengineering the experiences of Dr. Takanori Takebe, in the context of a research 
project carried out by a team led by the Cincinnati Children’s Center for Stem Cell and 
Organoid Medicine (CuSTOM) and Yokohama City University, who succeeded to 
create some liver tissues suitable for therapeutic transplantation by using skin cells, and 
                                                             
88 ARIAS DÍAZ, J., “Medicina regenerativa”, Enciclopeida de Bioderecho y Bioética, available at 
https://enciclopedia-bioderecho.com/voces/214 accessed 14 September 2018. AWAYA, T., “Common 
ethical issues in regenerative medicine”, Journal International de Bioéthique, n° 16(1-2)69-75, 2005 
March-June, pp. 192-193. 
89 ARJMAND, B., GOODARZI, P., MOHAMADI-JAHANI, F., FALAHZADEH, K., LARIJANI, B., 
“Personalized Regenerative Medicine”, Acta Med Iranica, n° 55(3), March 2017, pp. 144-149. 
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of the American company Organovo, that similarly succeeded to print liver tissues with 
its 3D NovoGen BioPrinting.
90
 
Under this premise, the admissibility of this kind of practices, capable of having an 
important impact on the human body through its manipulation, either genetic or not, 
was affirmed in scholarship by supporters of transhumanism by claiming that identity is 
the result of each individual’s will. It is the human being to “structure”, to define his 
own identity. From a more moderate but, possibly, argumentatively stronger viewpoint, 
we could consider these issues as a matter of autonomy, which would also help to tackle 
the risks of being ideological highlighted by Professor Rodotà and would help to bridge 
possible gaps with human dignity.
91
  
 Of course, some legislative efforts at all levels would be indispensable for 
preventing discriminatory practices and eugenic drifts: international guidance for 
concerted domestic implementation is of fundamental importance. Risks of 
discrimination and stigmatisation might be posed not only when diagnosis might lead to 
discovering the susceptibility to a given disease, for example through genetic testing, 
but misuse of the therapeutic means itself might lead to such distorted consequences as 
inequal allocation of the means available or even to serious social injustice. For 
example, by creating an élite of subjects who would enjoy of improvement of their 
potential due to their privileged social status. Another serious risk, possibly more 
dystopic but not unlikely, is the use of advanced therapeutic means for creating a 
subdued working class, that might recall the dystopia described in Aldous Huxley’s 
masterpiece Brave New World.
92
  
7. ADVANCING SOME POSSIBLE EVOLUTION IN EUROPE 
The content of the right to health in the EU and in the COE has to be read 
consistently with the common core elaborated in the international landscape that, as 
                                                             
90 MURPHY, S. V., ATALA, A., “3D bioprinting of tissues and organs”, Nature Biotechnologies, n° 32 
(8), August 2014, pp. 773-785. RODRÍGUEZ MERINO, J. M., Ética y derechos humanos en la era 
biotecnológica, Madrid, Dykinson, 2015. 
91 BOSTROM, N., “In defence of posthuman dignity”, Bioethics, n° 19 (3), 2005, pp. 202-214. 
92 HUXLEY, A., Brave New World, London, Chatto & Windus, 1932. 
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authoritatively observed in scholarship, has come to amount to an international opinio 
iuris. 
However, the point is whether this “incorporation” may help to improve the 
protection of the right to health and the right to access to health care in the framework 
of the EU and of the COE for facing the challenges of the Anthropocene, especially 
through the use of the most advanced solutions made available by scientific progress. 
Thus, primarily, possible ways of integration are considered to subsequently suggest 
how the protection may be enhanced. 
The EU would clearly benefit from some internationally shared guidance when 
elaborating its policies at the intersection between health and environment and similarly 
when interpreting and applying Article 35 of the CFR, given the programmatic nature of 
this provision. This would also concur to enhance justiciability before the ECJ and to 
positively affect Member States’ implementation of EU law concerning both health and 
environmental sector in their domestic legal orders, in line with the scope of application 
of the CFR as defined in Article 51(1) therein. 
Similarly, reference to the internationally shared conception of the right to health 
would benefit the case law of the Strasbourg Court. For example, through a – long 
awaited - environmental reading of Article 3 of the ECHR for providing adequate 
responses to the threats posed by the Anthropocene to human health, consistently with 
the relevant lines of jurisprudence elaborated so far. Any achievement of the ECtHR 
would also benefit the protection ensured by the EU pursuant to Article 52(3) of the 
CFR, where it identifies the minimum scope and meaning of the entitlements enshrined 
in the CFR by reference to the ECHR. Again, in the post-Lisbon framework, the level of 
protection elaborated in the Strasbourg jurisprudence is a standard of evaluation of the 
legitimacy of EU’s policies and actions, in line with Article 6 of the TEU. 
The point is now how the content of the right to health and to access to health care 
may be reconsidered in the EU and in the COE in light of these considerations with 
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regard to the challenges of the Anthropocene and whether it allows a bioethically-
oriented reading, also capable of embracing accessibility to biomedical progress.  
Some possible but not exhaustive paths are advanced. Primarily, reference to the 
4As-Scheme would help and, especially, its reading in light of the principles of 
bioethics. 
From a social perspective, “availability” and “accessibility” would benefit from 
some reference to the principles of solidarity, justice, universality and vulnerability, in 
order to promote an equal allocation of resources - that should be made available in 
sufficient quantity and without discrimination - also capable of minimizing the risks of 
commodification of vulnerable subjects. For example, vulnerability would prompt 
socially and economically disadvantaged people to join medical experimentation, 
because they wish for some financial gain or for accessing therapies that are not yet 
available in the pharmaceutical market. Sometimes, when the burden of the costs of 
health care is not adequately assumed by the public sphere, medical experimentation 
may result to be the only feasible way to access medications for the poorest. Again, 
economic accessibility entails that resources be affordable for everyone. The reading 
advanced seems to suit the criteria of allocation of health resources represented by 
“rights” according to Professor Daniels’ classification, that the EU has embraced, and 
also seems to be consistent with a human rights-based approach in the framework of the 
COE. 
Similarly, it may be argued that the standards of accessibility and acceptability 
would benefit from some reference to the bioethical principles concerning the individual 
sphere, as non-maleficence and beneficence, autonomy and information which would 
respectively improve the access to specific information on health and Anthropocene and 
education on individual approach to the risks connected. Furthermore, these principles 
would enhance the respect for medical ethics and cultural appropriateness of medical 
services and assistance. A similar consideration may be put forward with regard to the 
standard of quality, where it implies that “goods and services be scientifically and 
medically appropriate and of good quality”. In this sense, health care should be 
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adequate to meet the challenges of the Anthropocene, which also means appropriate 
education and skills of the medical personnel.  Again, it may also provide some 
justification for the incorporation of instruments made available by biomedical progress, 
in order to ensure adequate quality of health care in response to the specific health risks 
posed by the Anthropocene, which may not always be coped with according to usual 
medical protocols and means. It is in this regard that the advanced techniques taken into 
consideration in this study may be a helpful reference, human therapeutic cloning, 
pharmacogenetics, pharmacogenomics and regenerative medicine. Of course, human 
germline editing too may be a helpful solution to take into account: however, still the 
normative and ethical approach to the admissibility of this kind of intervention need 
scientific evidence of its benefits and of its safety to make the time ripe for acceptance. 
Nevertheless, surely time is ripe for the discussion, as the experience of the United 
Kingdom with MRT demonstrates. 
 Last but not least, human dignity would underpin accessibility to advanced 
biomedical preventive and therapeutic solutions as a means for enabling human beings 
to enjoy a dignified existence and the full personal development when facing up to the 
adverse impact of the Anthropocene on their health. Which is exactly what was 
desirable in the views of Julian Huxley. 
The view advanced may find some further enhancement by reference to Article 15 
of the ICESCR - it is noteworthy that all European States have signed and ratified it - 
and to the system of the Oviedo Convention, consistently with Article 31(3)(c) of the 
Vienna Convention on the Law of the Treaties. 
In fact, under Article 15 of the ICESCR, that enshrines the right to enjoy the 
benefits of scientific progress, States are bound to take steps “to achieve the full 
realization of this right” [that] shall include [the actions] necessary for the conservation, 
the development and the diffusion of science and culture”. States are under positive and 
negative obligations in light with their threefold duty to respect, to protect and to 
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 which addresses for example, the freedom of research but also ensuring 
availability and accessibility of scientific progress not only in the public sphere but also 
in those areas of privatization and commercialization of science and health. In this 
regard, some precious guidance will be provided by the forthcoming General Comment 
on the right to science on Article 15(1)(b), which will be soon adopted by the 
Committee on Economic, Social and Cultural Rights. However, in the meantime, some 
helpful interpretive guidance can be offered by Article 27 of the Universal Declaration 
on Human Rights (UDHR),
94
 which is the archetype of UN human rights treaties.  
In fact, interpretive reference to Article 27 of the UDHR would provide some 
justification to the adoption of an inclusive and democratic approach to States duties 
under the right to enjoy the benefits of scientific progress. This is so because this 
provision foresees that everyone has the rights to “share in scientific advancement and 
its benefits” which, through reference to the verbs “participer” and “participar” 
respectively used in the French and Spanish version of the UDHR, should be intended 
as the right to actively participate in scientific progress and its benefits.
95
 This seems all 
the more true when one considers that, according to Article 15(2) of the ICESCR, States 
are under an obligation to take all the steps to achieve the “full realization” of this 
rights, “includ[ing] those necessary for the conservation, the development and the 
diffusion of science”. 
Moreover, it may be argued that this view appears consistent with the rationale 
underlying the conception of “benefit sharing”, that is contemplated in Article 12 of the 
UNESCO Universal Declaration on Human Genome and Human Rights, which 
provides that “benefits from advances in biology, genetics and medicine, concerning the 
                                                             
93 See DONDERS, Y., “The right to enjoy the benefits of scientific progress: in search of state obligations 
in relation to health”, Medicine, Health Care, and Philosophy, n° 14 (4), November 2011, pp. 371–381. 
94 UN General Assembly, Universal Declaration of Human Rights, 10 December 1948, 217 A (III), 
available at http://www.un.org/en/universal-declaration-human-rights/ accessed 14 September 2018. 
95 MANCISIDOR, M., “Is There Such a Thing as a Human Right to Science in International Law? “, 
ESIL Reflections, n° 4(1), (7 April 2015), available at http://www.esil-sedi.eu/node/896 last visited 13 
September 2018; MANCISIDOR, M., “Historia del Derecho Humano a la Ciencia”, in Die Subversive 
Kraft der Menchenrechte, HUHLE, N., HUHLE, T., (eds.), Oldenburg, Paulo Freire Verlag, 2015. For 
further views and assessments on human rights in general and, in particular, on the right to science, it may 
also be interesting to visit the blog of Professor Mikel Mancisidor at http://mikelmancisidor.blogspot.it/.  
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human genome, shall be made available to all”.  Some further clarification and guidance 
on the understanding of the conception of benefit sharing and on the possibility to 
consider it from a socially inclusive perspective are offered by Article 19 of the 
UNESCO International Declaration on Human Genetic Data, where it provides that 
“benefits […] should be shared with the society as a whole and the international 
community”. In practice, States shall provide effectiveness to this principle by ensuring 
“provision of new diagnostics, facilities for new treatments or drugs stemming from the 
research” besides “support to health services”.  
The view advanced above may arguably provide some justification under 
international law to the theorization of accessibility to healthcare as also including 
genome editing, human therapeutic cloning, pharmacogenetics and pharmacogenomics 
and regenerative medicine, in light of a human rights-based approach and as a way of 
understanding benefit sharing, as a response to the threats posed by the Anthropocene to 
human health and integrity. Of course, adequate assessment of the risks connected to 
such advanced applications as genome editing, human therapeutic cloning, 
pharmacogenetics or pharmacogenomics ad regenerative medicine is fundamental. In 
this respect, the precautionary principle should be taken into consideration as a 
reference of primary importance. 
Also the Oviedo Convention and its Additional Protocols may be helpful for 
developing a regional human rights-based approach. This may be argued because they 
have proven capable of enhancing the protection of fundamental rights, especially in 
relation to access to healthcare and the enjoyment of some advanced biorights, when 
used as a support to the interpretation of the ECHR, as the case law of the ECtHR has 
demonstrated on many occasions - the cases mentioned in the section on the COE are 
emblematic examples, as for instance the Costa and Pavan judgment. Surely, the COE’s 
system would be a helpful reference also for the interpretation of the CFR – especially 
pursuant to Article 52(3) CFR - and EU law in general. Due to the epigenetic impact of 
the Anthropocene and the progress and promises of personalized medicine, particular 
attention is devoted here to the Additional Protocol on Genetic Testing for Health 
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Purposes. It seems relevant to stress especially the importance of the principle of non-
discrimination ad non-stigmatisation on the grounds of the genetic heritage embodied in 
Article 4, which sets a specific prohibition in this respect. This principle is also 
contemplated by the UNESCO Universal Declaration on Human Genome and Human 
Rights at Article 6, according to which “no one shall be subject to discrimination based 
on genetic characteristics that is intended to infringe or has the effect of infringing 
human rights, fundamental freedoms and human dignity” and by the UNESCO 
International Declaration on Human Genetic Data at Article 7, which also includes 
reference to proteomic data and which extends the protection it ensures to the  
stigmatization of an individual, a family, a group or communities.    
The importance of genetic testing is closely related to access to personalized 
medicine, and to customized therapeutic approaches as pharmacogenetics or 
pharmacogenomics. This is why ensuring adequate and effective protection to the 
genetic information resulting from genetic testing should be a basic goal for States when 
defining their policies in this regard, which may be intended as a way for adopting the 
“appropriate measures [for] prevent[ing] stigmatisation of persons or groups in relation 
to genetic characteristics” pursuant to above-mentioned Article 4(2) of the Additional 
Protocol on Genetic Testing for Health Purposes. This kind of discriminations, indeed, 
might assume particular importance in those countries that adopt an insurance-based 
health system, as it is more likely to affect persons with a genetic predisposition to a 
disease that might be triggered by the Anthropocene.  
8. CONCLUSIONS 
Which evolution can we reasonably expect? Possibly, we can be reasonably but 
wisely expect some improvement of accessibility of healthcare from a general 
viewpoint. The EU and the COE so far have proven quite capable of handling the 
weaknesses in their systems, normatively and judicially. In this regard, we can expect a 
growing engagement, in line with the international increasing efforts in tackling the 
Anthropocene. In practice, combined strategies seem the most suitable option: 
managing the impact of the Anthropocene, requires combined action that addresses both 
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the environmental and the health sphere. Improvement of living conditions (for 
example: food and water security; reduction of pollution; enhanced preventive health 
care; investing in research) is basic; although costly, in the long term is rewarding, just 
like ensuring equal access to health care. Again, the relentless progress of biomedicine 
and biotechnology is likely to provide new resources and make them available, 
accessible and more affordable for a growing part of the population. Of course, 
pharmacogenetics or pharmacogenomics, regenerative medicine, human cloning for 
therapeutic purposes and all therapeutic interventions concerning the human genome, 
especially human germline alterations, still require time and further scientific evidence 
of the benefit they can offer in the short and long term. However, the fact that some 
techniques, as the mitochondrial replacement therapy, are already available and can help 
to improve the health and the living conditions of the descendants and, in a prospective 
way, of the future generations, makes it compelling to define a human rights-based 
approach. As Professor Rodotà said, human rights can be more effective than 
prohibitions; and, arguably, we can suggest that human germline modifications and 
human therapeutic cloning should be wisely reconsidered, but responsibly. A bioethical 
approach may arguably be the reasonable solution for elaborating rules that can ensure 
adequate protection to the human being, especially to the most vulnerable persons. This 
may be the viable path to ensure that human nature can express its potentiality without 
being distorted or used for serving unethical purposes, even through the exploitation of 
the most vulnerable subjects, for example in the experimentation.  
Human rights law and bioethics will play a fundamental role to ensure social justice 
and hopefully mark the Anthropocene as the era when law stopped “lag[ging] behind 
science” or, at least, succeeded to keep pace with it better than it has done so far. 
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